false Q2 --12-31 0001868419 0001868419 2025-01-01 2025-06-30 0001868419 CYCU:CommonStockParValue0.0001PerShareMember 2025-01-01 2025-06-30 0001868419 CYCU:RedeemableWarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember 2025-01-01 2025-06-30 0001868419 2025-08-08 0001868419 2025-06-30 0001868419 2024-12-31 0001868419 us-gaap:NonrelatedPartyMember 2025-06-30 0001868419 us-gaap:NonrelatedPartyMember 2024-12-31 0001868419 us-gaap:RelatedPartyMember 2025-06-30 0001868419 us-gaap:RelatedPartyMember 2024-12-31 0001868419 CYCU:SeriesAConvertiblePreferredStockMember 2025-06-30 0001868419 CYCU:SeriesAConvertiblePreferredStockMember 2024-12-31 0001868419 CYCU:SeriesBConvertiblePreferredStockMember 2025-06-30 0001868419 CYCU:SeriesBConvertiblePreferredStockMember 2024-12-31 0001868419 CYCU:SeriesCConvertiblePreferredStockMember 2025-06-30 0001868419 CYCU:SeriesCConvertiblePreferredStockMember 2024-12-31 0001868419 CYCU:SeriesDConvertiblePreferredStockMember 2025-06-30 0001868419 CYCU:SeriesDConvertiblePreferredStockMember 2024-12-31 0001868419 CYCU:SeriesEConvertiblePreferredStockMember 2025-06-30 0001868419 CYCU:SeriesEConvertiblePreferredStockMember 2024-12-31 0001868419 CYCU:SeriesFConvertiblePreferredStockMember 2025-06-30 0001868419 CYCU:SeriesFConvertiblePreferredStockMember 2024-12-31 0001868419 CYCU:SeriesGConvertiblePreferredStockMember 2025-06-30 0001868419 CYCU:SeriesGConvertiblePreferredStockMember 2024-12-31 0001868419 CYCU:SeriesAOneConvertiblePreferredStockMember 2025-06-30 0001868419 CYCU:SeriesAOneConvertiblePreferredStockMember 2024-12-31 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2025-06-30 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2024-12-31 0001868419 2025-04-01 2025-06-30 0001868419 2024-04-01 2024-06-30 0001868419 2024-01-01 2024-06-30 0001868419 2023-12-31 0001868419 2024-06-30 0001868419 us-gaap:PreferredStockMember CYCU:SeriesAConvertiblePreferredStockMember 2024-12-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2024-12-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesCConvertiblePreferredStockMember 2024-12-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesDConvertiblePreferredStockMember 2024-12-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesFConvertiblePreferredStockMember 2024-12-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesGConvertiblePreferredStockMember 2024-12-31 0001868419 us-gaap:CommonStockMember 2024-12-31 0001868419 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001868419 us-gaap:RetainedEarningsMember 2024-12-31 0001868419 us-gaap:ParentMember 2024-12-31 0001868419 us-gaap:NoncontrollingInterestMember 2024-12-31 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesAConvertiblePreferredStockMember 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesCConvertiblePreferredStockMember 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesDConvertiblePreferredStockMember 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesFConvertiblePreferredStockMember 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesGConvertiblePreferredStockMember 2025-03-31 0001868419 us-gaap:CommonStockMember 2025-03-31 0001868419 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001868419 us-gaap:RetainedEarningsMember 2025-03-31 0001868419 us-gaap:ParentMember 2025-03-31 0001868419 us-gaap:NoncontrollingInterestMember 2025-03-31 0001868419 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2023-12-31 0001868419 us-gaap:CommonStockMember 2023-12-31 0001868419 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001868419 us-gaap:RetainedEarningsMember 2023-12-31 0001868419 us-gaap:ParentMember 2023-12-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2024-03-31 0001868419 us-gaap:CommonStockMember 2024-03-31 0001868419 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001868419 us-gaap:RetainedEarningsMember 2024-03-31 0001868419 us-gaap:ParentMember 2024-03-31 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2025-01-01 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesAConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesCConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesDConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesFConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesGConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001868419 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001868419 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001868419 us-gaap:ParentMember 2025-01-01 2025-03-31 0001868419 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001868419 2025-01-01 2025-03-31 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2025-04-01 2025-06-30 0001868419 us-gaap:PreferredStockMember CYCU:SeriesAConvertiblePreferredStockMember 2025-04-01 2025-06-30 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2025-04-01 2025-06-30 0001868419 us-gaap:PreferredStockMember CYCU:SeriesCConvertiblePreferredStockMember 2025-04-01 2025-06-30 0001868419 us-gaap:PreferredStockMember CYCU:SeriesDConvertiblePreferredStockMember 2025-04-01 2025-06-30 0001868419 us-gaap:PreferredStockMember CYCU:SeriesFConvertiblePreferredStockMember 2025-04-01 2025-06-30 0001868419 us-gaap:PreferredStockMember CYCU:SeriesGConvertiblePreferredStockMember 2025-04-01 2025-06-30 0001868419 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001868419 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001868419 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001868419 us-gaap:ParentMember 2025-04-01 2025-06-30 0001868419 us-gaap:NoncontrollingInterestMember 2025-04-01 2025-06-30 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2024-01-01 2024-03-31 0001868419 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001868419 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001868419 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001868419 us-gaap:ParentMember 2024-01-01 2024-03-31 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2024-04-01 2024-06-30 0001868419 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001868419 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001868419 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001868419 us-gaap:ParentMember 2024-04-01 2024-06-30 0001868419 us-gaap:PreferredStockMember CYCU:SeriesAConvertiblePreferredStockMember 2025-06-30 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2025-06-30 0001868419 us-gaap:PreferredStockMember CYCU:SeriesCConvertiblePreferredStockMember 2025-06-30 0001868419 us-gaap:PreferredStockMember CYCU:SeriesDConvertiblePreferredStockMember 2025-06-30 0001868419 us-gaap:PreferredStockMember CYCU:SeriesFConvertiblePreferredStockMember 2025-06-30 0001868419 us-gaap:PreferredStockMember CYCU:SeriesGConvertiblePreferredStockMember 2025-06-30 0001868419 us-gaap:CommonStockMember 2025-06-30 0001868419 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001868419 us-gaap:RetainedEarningsMember 2025-06-30 0001868419 us-gaap:ParentMember 2025-06-30 0001868419 us-gaap:NoncontrollingInterestMember 2025-06-30 0001868419 us-gaap:PreferredStockMember CYCU:SeriesBConvertiblePreferredStockMember 2024-06-30 0001868419 us-gaap:CommonStockMember 2024-06-30 0001868419 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001868419 us-gaap:RetainedEarningsMember 2024-06-30 0001868419 us-gaap:ParentMember 2024-06-30 0001868419 CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 CYCU:SeriesAWarrantsMember CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 CYCU:SeriesBWarrantsMember CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 CYCU:SeriesDWarrantsMember CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 CYCU:CommonStockWarrantMember CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 CYCU:SeriesDPrivatePlacementMember CYCU:WesternAcquisitionVenturesCorpMember 2025-02-14 2025-02-14 0001868419 CYCU:AllianceGlobalPartnersMember us-gaap:CommonStockMember 2025-02-14 2025-02-14 0001868419 CYCU:SewardAndKisselLLPMember us-gaap:CommonStockMember 2025-02-14 2025-02-14 0001868419 CYCU:BakerAndHostetlerLLPMember us-gaap:CommonStockMember 2025-02-14 2025-02-14 0001868419 2025-04-09 0001868419 srt:MinimumMember 2025-04-09 0001868419 2025-04-11 2025-04-11 0001868419 2025-04-11 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2025-01-01 2025-06-30 0001868419 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2025-06-30 0001868419 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2025-06-30 0001868419 CYCU:CapitalLeaseMember 2025-06-30 0001868419 us-gaap:SoftwareDevelopmentMember 2025-06-30 0001868419 CYCU:AdvisoryConsultingMember 2025-04-01 2025-06-30 0001868419 CYCU:AdvisoryConsultingMember 2024-04-01 2024-06-30 0001868419 CYCU:AdvisoryConsultingMember 2025-01-01 2025-06-30 0001868419 CYCU:AdvisoryConsultingMember 2024-01-01 2024-06-30 0001868419 CYCU:ManagedSecurityServicePracticeMember 2025-04-01 2025-06-30 0001868419 CYCU:ManagedSecurityServicePracticeMember 2024-04-01 2024-06-30 0001868419 CYCU:ManagedSecurityServicePracticeMember 2025-01-01 2025-06-30 0001868419 CYCU:ManagedSecurityServicePracticeMember 2024-01-01 2024-06-30 0001868419 CYCU:SoftwareAsAServiceMember 2025-04-01 2025-06-30 0001868419 CYCU:SoftwareAsAServiceMember 2024-04-01 2024-06-30 0001868419 CYCU:SoftwareAsAServiceMember 2025-01-01 2025-06-30 0001868419 CYCU:SoftwareAsAServiceMember 2024-01-01 2024-06-30 0001868419 us-gaap:EquipmentMember 2025-06-30 0001868419 us-gaap:EquipmentMember 2024-12-31 0001868419 us-gaap:FurnitureAndFixturesMember 2025-06-30 0001868419 us-gaap:FurnitureAndFixturesMember 2024-12-31 0001868419 us-gaap:LeaseholdImprovementsMember 2025-06-30 0001868419 us-gaap:LeaseholdImprovementsMember 2024-12-31 0001868419 CYCU:CapitalLeaseMember 2024-12-31 0001868419 CYCU:SoftwareMember 2025-06-30 0001868419 CYCU:SoftwareMember 2024-12-31 0001868419 us-gaap:SoftwareDevelopmentMember 2025-04-01 2025-06-30 0001868419 us-gaap:SoftwareDevelopmentMember 2024-04-01 2024-06-30 0001868419 us-gaap:SoftwareDevelopmentMember 2025-01-01 2025-06-30 0001868419 us-gaap:SoftwareDevelopmentMember 2024-01-01 2024-06-30 0001868419 CYCU:ContractualRelationshipMember 2025-06-30 0001868419 CYCU:ContractualRelationshipMember 2024-12-31 0001868419 CYCU:ImplementationMember 2025-06-30 0001868419 CYCU:ImplementationMember 2024-12-31 0001868419 CYCU:SoftwareMember 2025-06-30 0001868419 CYCU:SoftwareMember 2024-12-31 0001868419 CYCU:SLGInnovationIncMember 2020-12-31 0001868419 CYCU:SLGInnovationIncMember 2024-12-31 0001868419 CYCU:SLGInnovationIncMember 2023-04-29 0001868419 CYCU:SLGInnovationIncMember 2023-04-29 2023-04-29 0001868419 CYCU:SLGInnovationIncMember CYCU:ReleaseAgreementMember 2025-06-30 0001868419 CYCU:SLGInnovationIncMember 2025-01-01 2025-06-30 0001868419 CYCU:SLGInnovationIncMember 2025-06-30 0001868419 CYCU:SLGInnovationIncMember us-gaap:SeriesEPreferredStockMember 2025-06-30 0001868419 CYCU:SLGInnovationIncMember CYCU:InitialAllocationOfAssetsAndLiabilitiesMember 2025-06-30 0001868419 CYCU:SLGInnovationIncMember CYCU:AdjustmentsMember 2025-06-30 0001868419 CYCU:SLGInnovationIncMember CYCU:EstimatedAllocationOfAssetsAndLiabilitiesMember 2025-06-30 0001868419 2025-06-03 0001868419 CYCU:AxxumTechnologiesLLCMember CYCU:ShareTransferAgreementMember 2017-11-22 0001868419 CYCU:AxxumTechnologiesLLCMember CYCU:ShareTransferAgreementMember CYCU:TwoMember 2017-11-22 0001868419 CYCU:AxxumTechnologiesLLCMember CYCU:ShareTransferAgreementMember 2017-11-22 2017-11-22 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember CYCU:OneEquityHolderMember 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember CYCU:TwoEquityHolderMember 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember CYCU:OneEquityHolderMember 2019-04-03 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember CYCU:TwoEquityHolderMember 2019-04-03 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember 2019-04-03 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:ShareTransferAgreementMember 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:ShareTransferAgreementMember 2019-04-03 2019-04-03 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember 2022-04-20 0001868419 CYCU:CloudburstSecurityLLCMember CYCU:MembershipInterestPurchaseAgreementMember 2022-04-20 2022-04-20 0001868419 CYCU:CloudburstSecurityLLCMember 2020-01-01 2020-12-31 0001868419 CYCU:CloudburstSecurityLLCMember 2025-06-30 0001868419 CYCU:SLGInnovationIncMember srt:MaximumMember 2024-12-31 0001868419 CYCU:SLGInnovationIncMember 2025-03-31 0001868419 CYCU:SLGInnovationIncMember us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001868419 CYCU:SLGInnovationIncMember us-gaap:SeriesEPreferredStockMember 2025-01-01 2025-03-31 0001868419 CYCU:SLGInnovationIncMember 2025-01-01 2025-03-31 0001868419 CYCU:AxxumTechnologiesLLCMember 2025-06-30 0001868419 CYCU:AxxumTechnologiesLLCMember 2024-12-31 0001868419 CYCU:CloudburstSecurityLLCMember 2024-12-31 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2017-11-22 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2017-11-22 2017-11-22 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2019-04-18 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2019-04-18 2019-04-18 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2021-06-30 2021-06-30 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2020-06-29 2020-06-29 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2025-01-01 2025-06-30 0001868419 CYCU:BankLoanRevolvingCreditLineMember 2025-06-30 0001868419 CYCU:BankLoanRevolvingCreditLineMember CYCU:AxxumLoanMember 2025-01-01 2025-06-30 0001868419 CYCU:BankLoanRevolvingCreditLineMember CYCU:LoanAndSecurityAgreementMember 2019-04-18 2019-04-18 0001868419 CYCU:BankLoanRevolvingCreditLineMember CYCU:LoanAndSecurityAgreementMember 2020-06-29 2020-06-29 0001868419 CYCU:BankLoanRevolvingCreditLineMember CYCU:LoanAndSecurityAgreementMember 2020-06-29 2020-06-29 0001868419 CYCU:BankLoanRevolvingCreditLineMember CYCU:LoanAndSecurityAgreementMember 2020-06-27 2020-06-29 0001868419 CYCU:SLGInnovationIncMember 2025-06-30 0001868419 CYCU:SLGInnovationIncMember 2024-12-31 0001868419 CYCU:CycurionMember 2025-06-30 0001868419 CYCU:CycurionMember 2024-12-31 0001868419 2023-03-20 2023-03-20 0001868419 2023-03-20 0001868419 CYCU:PromissoryNoteMember 2020-07-16 2020-07-16 0001868419 CYCU:EIDLLoanMember 2020-07-16 0001868419 CYCU:EIDLLoanMember 2020-07-16 2020-07-16 0001868419 CYCU:EIDLLoanMember 2025-06-30 0001868419 CYCU:EIDLLoanMember 2024-12-31 0001868419 CYCU:EIDLLoanMember CYCU:SLGInnovationIncMember 2020-09-30 2020-09-30 0001868419 CYCU:EIDLLoanMember CYCU:SLGInnovationIncMember 2020-09-30 0001868419 2017-12-31 0001868419 srt:MinimumMember 2017-12-31 0001868419 srt:MaximumMember 2017-12-31 0001868419 us-gaap:ConvertibleNotesPayableMember 2024-12-31 0001868419 us-gaap:ConvertibleNotesPayableMember 2025-01-01 2025-03-31 0001868419 us-gaap:ConvertibleNotesPayableMember 2025-03-31 0001868419 2024-01-01 2024-12-31 0001868419 us-gaap:ConvertibleNotesPayableMember 2025-04-01 2025-06-30 0001868419 us-gaap:ConvertibleNotesPayableMember 2025-06-30 0001868419 CYCU:PromissoryNotesMember 2024-12-31 0001868419 CYCU:PromissoryNotesMember 2025-01-01 2025-03-31 0001868419 CYCU:PromissoryNotesMember 2025-03-31 0001868419 CYCU:PromissoryNotesMember 2025-04-01 2025-06-30 0001868419 CYCU:PromissoryNotesMember 2025-06-30 0001868419 CYCU:PromissoryNotesOneMember 2025-06-30 0001868419 CYCU:PromissoryNotesOneMember 2024-12-31 0001868419 CYCU:PromissoryNotesOneMember 2025-01-01 2025-06-30 0001868419 CYCU:PromissoryNotesTwoMember 2025-06-30 0001868419 CYCU:PromissoryNotesTwoMember 2024-12-31 0001868419 CYCU:PromissoryNotesTwoMember 2025-01-01 2025-06-30 0001868419 CYCU:PromissoryNotesThreeMember 2025-06-30 0001868419 CYCU:PromissoryNotesThreeMember 2024-12-31 0001868419 CYCU:PromissoryNotesThreeMember srt:MinimumMember 2025-01-01 2025-06-30 0001868419 CYCU:PromissoryNotesThreeMember srt:MaximumMember 2025-01-01 2025-06-30 0001868419 CYCU:PromissoryNotesFourMember 2025-06-30 0001868419 CYCU:PromissoryNotesFourMember 2024-12-31 0001868419 CYCU:PromissoryNotesFourMember 2025-01-01 2025-06-30 0001868419 CYCU:PromissoryNotesFiveMember 2025-06-30 0001868419 CYCU:PromissoryNotesFiveMember 2024-12-31 0001868419 CYCU:PromissoryNotesFiveMember 2025-01-01 2025-06-30 0001868419 CYCU:PromissoryNotesSixMember 2025-06-30 0001868419 CYCU:PromissoryNotesSixMember 2024-12-31 0001868419 CYCU:PromissoryNotesSixMember srt:MinimumMember 2025-01-01 2025-06-30 0001868419 CYCU:PromissoryNotesSixMember srt:MaximumMember 2025-01-01 2025-06-30 0001868419 CYCU:SixInvestorMember 2022-03-22 0001868419 2022-03-22 0001868419 CYCU:ThreeInvestorsMember 2022-03-22 0001868419 CYCU:FifthInvestorsMember 2022-03-22 0001868419 CYCU:SixthInvestorsMember 2022-03-22 0001868419 CYCU:UnaffiliatedInvestorMember 2022-11-22 0001868419 2022-11-22 2022-11-22 0001868419 2022-11-22 0001868419 CYCU:UnaffiliatedInvestorMember 2022-11-22 2022-11-22 0001868419 CYCU:BusinessCombinationAgreementMember 2022-11-21 0001868419 2023-11-21 0001868419 CYCU:BusinessCombinationAgreementMember 2025-01-01 2025-03-31 0001868419 CYCU:BusinessCombinationAgreementMember 2025-03-31 0001868419 CYCU:BusinessCombinationAgreementMember CYCU:SeriesDConvertiblePreferredStockMember 2025-01-01 2025-03-31 0001868419 CYCU:BusinessCombinationAgreementMember CYCU:SeriesDWarrantsMember CYCU:SevenUnaffiliatedInvestorMember 2025-01-01 2025-03-31 0001868419 2022-07-12 0001868419 CYCU:SeriesAConvertiblePreferredStockMember 2024-01-01 2024-12-31 0001868419 CYCU:SeriesAConvertiblePreferredStockMember srt:MinimumMember 2024-12-31 0001868419 CYCU:SeriesAConvertiblePreferredStockMember srt:MaximumMember 2024-12-31 0001868419 CYCU:SeriesAConvertiblePreferredStockMember us-gaap:PrivatePlacementMember CYCU:WesternAcquisitionVenturesCorpMember 2025-06-30 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2025-06-30 0001868419 CYCU:CommonClassSubjectToRedemptionMember 2024-12-31 0001868419 CYCU:SeriesAConvertiblePreferredStockMember 2025-01-01 2025-06-30 0001868419 CYCU:SeriesAConvertiblePreferredStockMember us-gaap:PrivatePlacementMember CYCU:WesternAcquisitionVenturesCorpMember 2025-03-31 0001868419 CYCU:SeriesAConvertiblePreferredStockMember us-gaap:PrivatePlacementMember CYCU:WesternAcquisitionVenturesCorpMember 2024-12-31 0001868419 us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-06-30 0001868419 CYCU:SeriesBConvertiblePreferredStockMember CYCU:WesternAcquisitionVenturesCorpMember 2025-03-31 0001868419 CYCU:SeriesBConvertiblePreferredStockMember CYCU:WesternAcquisitionVenturesCorpMember 2025-01-01 2025-06-30 0001868419 us-gaap:SeriesCPreferredStockMember 2025-06-30 0001868419 us-gaap:SeriesCPreferredStockMember 2025-01-01 2025-06-30 0001868419 CYCU:SeriesCConvertiblePreferredStockMember CYCU:WesternAcquisitionVenturesCorpMember 2025-01-01 2025-03-31 0001868419 CYCU:SeriesCConvertiblePreferredStockMember 2025-03-31 0001868419 us-gaap:SeriesDPreferredStockMember 2025-01-01 2025-06-30 0001868419 CYCU:SeriesDConvertiblePreferredStockMember CYCU:WesternAcquisitionVenturesCorpMember 2025-03-31 0001868419 CYCU:SeriesDConvertiblePreferredStockMember CYCU:WesternAcquisitionVenturesCorpMember 2025-01-01 2025-03-31 0001868419 CYCU:SeriesDConvertiblePreferredStockMember 2025-03-31 0001868419 us-gaap:SeriesEPreferredStockMember 2025-01-01 2025-06-30 0001868419 CYCU:SeriesEConvertiblePreferredStockMember CYCU:SLGInnovationMember 2025-03-31 0001868419 us-gaap:SeriesFPreferredStockMember 2025-06-30 0001868419 us-gaap:SeriesFPreferredStockMember 2025-01-01 2025-06-30 0001868419 us-gaap:SeriesGPreferredStockMember 2025-06-30 0001868419 us-gaap:SeriesGPreferredStockMember 2025-01-01 2025-06-30 0001868419 us-gaap:CommonStockMember CYCU:SeriesBandDConvertiblePreferredStockMember 2025-01-01 2025-06-30 0001868419 us-gaap:CommonStockMember CYCU:WarrantABandDMember 2025-01-01 2025-06-30 0001868419 us-gaap:CommonStockMember us-gaap:AcquisitionRelatedCostsMember 2025-01-01 2025-06-30 0001868419 us-gaap:CommonStockMember CYCU:SettlementOfDebtMember 2025-01-01 2025-06-30 0001868419 CYCU:SettlementOfDebtMember 2025-01-01 2025-06-30 0001868419 us-gaap:CommonStockMember CYCU:EmploymentAgreementMember 2025-01-01 2025-06-30 0001868419 us-gaap:CommonStockMember CYCU:SLGInnovationMember 2025-01-01 2025-06-30 0001868419 CYCU:CommonStockRedemptionMember 2025-01-01 2025-06-30 0001868419 CYCU:SLGInnovationMember 2025-06-30 0001868419 CYCU:PublicWarrantsMember 2025-06-30 0001868419 CYCU:PublicWarrantsMember 2024-12-31 0001868419 CYCU:PublicWarrantsMember 2025-01-01 2025-06-30 0001868419 CYCU:PrivatePlacementWarrantsMember 2025-06-30 0001868419 CYCU:PrivatePlacementWarrantsMember 2024-12-31 0001868419 CYCU:SeriesAWarrantsMember 2017-11-17 0001868419 CYCU:SeriesAWarrantsMember 2025-03-31 0001868419 CYCU:SeriesAWarrantsMember us-gaap:CommonStockMember 2025-03-31 0001868419 CYCU:SeriesBWarrantsMember 2023-08-01 0001868419 CYCU:SeriesBWarrantsMember 2024-04-12 0001868419 CYCU:SeriesBWarrantsMember 2025-03-31 0001868419 CYCU:SeriesBWarrantsMember us-gaap:CommonStockMember 2025-03-31 0001868419 CYCU:SeriesDWarrantsMember CYCU:SubordinatedConvertiblePromissoryNoteMember 2022-03-22 0001868419 CYCU:SeriesDWarrantsMember CYCU:SubordinatedConvertiblePromissoryNoteOneMember 2022-11-22 0001868419 CYCU:SeriesDWarrantsMember 2025-03-31 0001868419 CYCU:SeriesDWarrantsMember us-gaap:CommonStockMember 2025-03-31 0001868419 us-gaap:WarrantMember 2022-03-08 0001868419 us-gaap:WarrantMember 2022-03-08 2022-03-08 0001868419 CYCU:WarrantsMember 2025-03-31 0001868419 CYCU:WarrantsMember us-gaap:CommonStockMember 2025-03-31 0001868419 us-gaap:WarrantMember 2024-12-31 0001868419 us-gaap:WarrantMember 2024-01-01 2024-12-31 0001868419 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001868419 us-gaap:WarrantMember 2025-03-31 0001868419 us-gaap:WarrantMember 2025-04-01 2025-06-30 0001868419 us-gaap:WarrantMember 2025-06-30 0001868419 srt:MaximumMember 2025-06-30 0001868419 CYCU:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0001868419 CYCU:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0001868419 CYCU:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-06-30 0001868419 CYCU:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001868419 CYCU:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0001868419 CYCU:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0001868419 CYCU:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-06-30 0001868419 CYCU:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001868419 CYCU:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0001868419 CYCU:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0001868419 CYCU:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-06-30 0001868419 CYCU:CustomerCMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001868419 CYCU:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0001868419 CYCU:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0001868419 CYCU:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-06-30 0001868419 CYCU:CustomerDMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001868419 CYCU:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-06-30 0001868419 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CYCU:CustomerOneMember 2025-01-01 2025-06-30 0001868419 CYCU:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-06-30 0001868419 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CYCU:CustomerTwoMember 2025-01-01 2025-06-30 0001868419 CYCU:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-06-30 0001868419 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CYCU:CustomerThreeMember 2025-01-01 2025-06-30 0001868419 us-gaap:FairValueInputsLevel1Member 2024-12-31 0001868419 us-gaap:FairValueInputsLevel2Member 2024-12-31 0001868419 us-gaap:FairValueInputsLevel3Member 2024-12-31 0001868419 CYCU:SponsorMember 2024-09-20 0001868419 CYCU:SponsorMember 2024-09-20 2024-09-20 0001868419 CYCU:SponsorMember 2025-01-01 2025-06-30 0001868419 CYCU:PromissoryNoteMember 2025-01-01 2025-06-30 0001868419 CYCU:PromissoryNoteMember 2024-01-01 2024-06-30 0001868419 CYCU:TwoDirectorMember 2025-06-30 0001868419 CYCU:TwoDirectorMember 2024-12-31 0001868419 CYCU:TwoDirectorMember 2025-01-01 2025-06-30 0001868419 srt:DirectorMember 2025-06-30 0001868419 srt:DirectorMember 2024-12-31 0001868419 srt:DirectorMember 2025-01-01 2025-06-30 0001868419 CYCU:SeriesAConvertiblePreferredStockMember 2025-04-01 2025-06-30 0001868419 CYCU:SeriesAConvertiblePreferredStockMember 2024-04-01 2024-06-30 0001868419 CYCU:SeriesAConvertiblePreferredStockMember 2024-01-01 2024-06-30 0001868419 CYCU:SeriesBConvertiblePreferredStockMember 2025-04-01 2025-06-30 0001868419 CYCU:SeriesBConvertiblePreferredStockMember 2024-04-01 2024-06-30 0001868419 CYCU:SeriesBConvertiblePreferredStockMember 2025-01-01 2025-06-30 0001868419 CYCU:SeriesBConvertiblePreferredStockMember 2024-01-01 2024-06-30 0001868419 CYCU:SeriesCConvertiblePreferredStockMember 2025-04-01 2025-06-30 0001868419 CYCU:SeriesCConvertiblePreferredStockMember 2024-04-01 2024-06-30 0001868419 CYCU:SeriesCConvertiblePreferredStockMember 2025-01-01 2025-06-30 0001868419 CYCU:SeriesCConvertiblePreferredStockMember 2024-01-01 2024-06-30 0001868419 CYCU:SeriesDConvertiblePreferredStockMember 2025-04-01 2025-06-30 0001868419 CYCU:SeriesDConvertiblePreferredStockMember 2024-04-01 2024-06-30 0001868419 CYCU:SeriesDConvertiblePreferredStockMember 2025-01-01 2025-06-30 0001868419 CYCU:SeriesDConvertiblePreferredStockMember 2024-01-01 2024-06-30 0001868419 CYCU:SeriesEConvertiblePreferredStockMember 2025-04-01 2025-06-30 0001868419 CYCU:SeriesEConvertiblePreferredStockMember 2024-04-01 2024-06-30 0001868419 CYCU:SeriesEConvertiblePreferredStockMember 2025-01-01 2025-06-30 0001868419 CYCU:SeriesEConvertiblePreferredStockMember 2024-01-01 2024-06-30 0001868419 CYCU:AllianceGlobalPartnersMember CYCU:TransactionFeeMember 2025-01-01 2025-06-30 0001868419 CYCU:AllianceGlobalPartnersMember srt:MinimumMember CYCU:TransactionFeeMember 2025-01-01 2025-06-30 0001868419 CYCU:AllianceGlobalPartnersMember CYCU:TransactionFeeMember 2025-06-30 0001868419 CYCU:AllianceGlobalPartnersMember 2025-06-30 0001868419 CYCU:AllianceGlobalPartnersMember 2025-01-01 2025-06-30 0001868419 CYCU:AllianceGlobalPartnersMember CYCU:AmendedTransactionFeeMember 2025-01-01 2025-06-30 0001868419 CYCU:AllianceGlobalPartnersMember srt:MinimumMember CYCU:AmendedTransactionFeeMember 2025-01-01 2025-06-30 0001868419 CYCU:AllianceGlobalPartnersMember CYCU:AmendedTransactionFeeMember 2025-06-30 0001868419 CYCU:SewardAndKisselLLPMember 2024-11-27 2024-11-27 0001868419 CYCU:SewardAndKisselLLPMember 2024-11-27 0001868419 CYCU:SewardAndKisselLLPMember 2025-02-14 0001868419 CYCU:SewardAndKisselLLPMember 2025-02-14 2025-02-14 0001868419 CYCU:PreFundedWarrantMember CYCU:SewardAndKisselLLPMember 2025-02-14 0001868419 CYCU:BakerHostetlerLlpMember 2023-12-31 0001868419 CYCU:EquityPurchaseAgreementMember 2025-04-07 0001868419 CYCU:EquityPurchaseAgreementMember 2025-04-07 2025-04-07 0001868419 CYCU:PreFundedWarrantMember 2025-04-07 2025-04-07 0001868419 CYCU:PreFundedWarrantMember 2025-04-07 0001868419 CYCU:PreFundedWarrantMember 2025-04-01 2025-06-30 0001868419 CYCU:PreFundedWarrantMember 2025-01-01 2025-06-30 0001868419 CYCU:SponsorMember CYCU:NonRedemptionAgreementMember 2024-08-06 2024-08-06 0001868419 CYCU:SponsorMember CYCU:NonRedemptionAgreementMember 2024-10-08 2024-10-09 0001868419 2023-12-27 2023-12-27 0001868419 2023-12-27 0001868419 2024-10-30 2024-10-30 0001868419 2024-10-30 0001868419 srt:ChiefExecutiveOfficerMember CYCU:EmploymentAgreementMember 2024-12-01 2024-12-01 0001868419 srt:ChiefExecutiveOfficerMember CYCU:EmploymentAgreementMember 2025-01-01 2025-01-01 0001868419 CYCU:EquityIncentivePlanMember srt:ChiefExecutiveOfficerMember 2025-06-16 2025-06-16 0001868419 CYCU:EquityIncentivePlanMember srt:ChiefFinancialOfficerMember 2025-06-16 2025-06-16 0001868419 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0001868419 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001868419 CYCU:PreFundedWarrantMember us-gaap:SubsequentEventMember 2025-07-01 2025-07-31 0001868419 us-gaap:SubsequentEventMember CYCU:ExecutivesMember 2025-07-01 2025-07-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended: June 30, 2025

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the transition period from __________ to __________

 

Commission File Number: 001-41214

 

 

Cycurion, Inc.
(Exact name of registrant as specified in its charter)
     
Delaware   86-3720717

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

     
1640 Boro Place, Fourth Floor, McLean, VA   22102
(Address of principal executive office)   (Zip Code)
     
(888) 341-6680
Registrant’s telephone number, including the area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock, par value $0.0001 per share   CYCU   The NASDAQ Stock Market LLC
         
Redeemable warrants, each exercisable for one share of common stock at an exercise price of $11.50 per share   CYCUW   The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐   Accelerated filer ☐   Non-accelerated filer
Smaller reporting company   Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No

 

As of August 8, 2025, there were 51,426,037 shares of common stock outstanding.

 

 

 

 

 

 

Table of Contents to Second Quarter 2025 Form 10-Q  
Part I - FINANCIAL INFORMATION 3
Item 1. Financial Statements - (Unaudited) 3
  Consolidated Balance Sheets 3
  Consolidated Statements of Operations and Comprehensive (Loss)/Income 4
  Consolidated Statements of Cash Flows 5
  Consolidated Statements of Changes in Stockholders’ Equity 6
  Notes to the Unaudited Consolidated Financial Statements 7
  1. Organization and Description of Business 7
  2. Significant Accounting Policies 9
  3. Accounts Receivable, Net 15
  4. Property and Equipment, Net 15
  5. Software Development Costs 15
  6. Intangible Assets 16
  7. Business Combination 16
  8. Goodwill 18
  9. Bank Loans 19
  10. Loans Payable 20
  11. Convertible Notes 21
  12. Promissory Notes 22
  13. Factoring Liability 23
  14. Series A Convertible Preferred Stock 23
  15. Equity 23
  16. Concentrations, Risks and Uncertainties 29
  17. Fair Value Disclosures 30
  18. Related Party Transactions 30
  19. Earnings Per Share 31
  20. Commitments and Contingencies 32
  21. Subsequent Events 34
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 35
  Forward-Looking Statements 35
  General and Business Overview 36
  Financial Overview 39
  Results of Operations 39
  Liquidity and Capital Resources 40
  Critical Accounting Policies and Estimates 41
Item 3. Quantitative and Qualitative Disclosures about Market Risk 42
Item 4. Controls and Procedures 42
PART II - OTHER INFORMATION 43
Item 1. Legal Proceedings 43
Item 1A. Risk Factors 43
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 44
Item 3. Defaults upon Senior Securities 44
Item 4. Mine Safety Disclosures 44
Item 5. Other Information 44
Item 6. Exhibits 44
  SIGNATURES 45

 

2

 

 

PART I – FINANCIAL STATEMENTS

 

Item 1. Financial Statements

 

CYCURION, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

   June 30, 2025   December 31, 2024 
Assets:          
Cash and cash equivalents  $1,013,836   $38,742 
Restricted cash   -    2,048 
Accounts receivable, net   4,118,888    10,353,708 
Other receivables   400,072    434,391 
Prepaid expenses and other current assets   54,259    99,463 
Total current assets   5,587,055    10,928,352 
Deposit for acquisition target   -    2,000,000 
Property and equipment, net   16,832    20,321 
Software development costs   4,325,981    4,151,981 
Intangible assets, net   7,917    25,000 
Security deposits   10,351    10,351 
Goodwill   20,788,299    6,592,304 
Investments held in trust account   -    1,834,540 
Total non-current assets   25,149,380    14,634,497 
Total Assets  $30,736,435   $25,562,849 
Liabilities, Mezzanine and Stockholders’ Equity:          
Bank loan-revolving credit line  $3,236,167   $3,249,067 
Bank loan - current portion   620,078    774,095 
Loans payable - current portion   885,240    408,516 
Factoring liability   2,309,160    - 
Subordinated convertible promissory notes   -    3,333,335 
Promissory notes   2,669,626    2,486,989 
Loans payable - related parties   150,372    148,088 
Accounts payable   5,088,223    3,578,374 
Due to related party   18,000    - 
Accrued liabilities   3,848,247    3,601,242 
Excise tax payable   1,167,173    1,157,161 
Total current liabilities   19,992,286    18,736,867 
Loans payable - non-current portion   295,296    146,798 
Series A Convertible preferred stock ($0.001 par value, 500,000 shares designated, 0 and 345,528 issued and outstanding, respectively)   -    1,294,117 
Total non-current liabilities   295,296    1,440,915 
Total liabilities   20,287,582    20,177,782 
Commitments and contingencies (Note 20)   -    - 
Mezzanine Equity:          
Common stock subject to possible redemption, $0.0001 par value, 0 and 173,879 shares at redemption value of approximately $11.03 per share, respectively   -    1,917,309 
Stockholders’ Equity:          
Preferred stock ($0.0001 par value, 20,000,000 shares authorized)          
Series A convertible preferred stock ($0.0001 par value, 110,000 shares designated, 106,816 and 0 issued and outstanding, respectively)   11    - 
Series B convertible preferred stock ($0.0001 par value, 3,000 shares designated, 1 and 3,000 issued and outstanding, respectively)   -    - 
Series C convertible preferred stock ($0.0001 par value, 5,000 shares designated, 4,851 issued and outstanding)   -    - 
Series D convertible preferred stock ($0.0001 par value, 6,666,700 shares designated, 150,000 and 0 issued and outstanding, respectively)   15    - 
Series E convertible preferred stock ($0.0001 par value, 100 shares designated, 51 and 0 issued and outstanding, respectively)   -    - 
Series F convertible preferred stock ($0.0001 par value, 10,000 shares designated, 0 and 0 issued and outstanding, respectively)   -    - 
Series G convertible preferred stock ($0.0001 par value, 10,000 shares designated, 3,318 and 0 issued and outstanding, respectively)          
Common stock ($0.0001 par value, 100,000,000 shares authorized, 40,353,983 and 10,592,607 shares issued and outstanding, respectively)   4,036    1,059 
Additional paid in capital   32,661,282    6,670,060 
Accumulated deficit   (18,650,614)   (3,203,361)
Total stockholders’ equity attributable to Cycurion   14,014,730    3,467,758 
Equity attributable to noncontrolling interests   (3,565,877)   - 
Total stockholders’ equity   10,448,853    3,467,758 
Total liabilities and stockholders’ equity  $30,736,435   $25,562,849 

 

3

 

 

CYCURION, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS)/INCOME

(Unaudited)

 

   June 30, 2025   June 30, 2024   June 30, 2025   June 30, 2024 
   For the Three Months Ended   For the Six Months Ended 
   June 30, 2025   June 30, 2024   June 30, 2025   June 30, 2024 
Net revenues  $3,887,915   $5,001,312   $7,757,965   $9,244,167 
Cost of revenues   3,651,978    3,977,150    6,844,265    7,873,291 
Gross profit   235,937    1,024,162    913,700    1,370,876 
Operating expenses:                    
Selling, general and administrative expenses   4,002,014    294,790    14,777,281    673,767 
Operating (loss)/income   (3,766,077)   729,372    (13,863,581)   697,109 
Interest income   -    20,211    -    20,211 
Interest expense   (615,392)   (482,355)   (794,283)   (713,830)
Loss on debt settlement, net   (907,983)   -    (766,330)   - 
Other (expense)/income   (962)   38,866    (114,706)   (9,871)
Other expense, net   (1,524,337)   (423,278)   (1,675,319)   (703,490)
(Loss)/income before income taxes   (5,290,414)   306,094    (15,538,900)   (6,381)
Provision for income tax   -    -    -    - 
Net (loss)/income   (5,290,414)   306,094    (15,538,900)   (6,381)
Less: Net loss attributable to non-controlling interest   101,659   -    101,659   - 
Net (loss)/income attributable to Cycurion  $(5,188,755)  $306,094   $(15,437,241)  $(6,381)
                     
Comprehensive (loss)/income  $(5,188,755)  $306,094   $(15,437,241)  $(6,381)
Earnings per share:                    
Basic  $(0.15)  $0.02   $(0.58)  $(0.00)
Diluted  $(0.15)  $0.01   $(0.57)  $(0.00)
Weighted average shares outstanding:                    
Basic   34,791,716    14,968,215    26,707,978    14,968,215 
Diluted   34,891,716    32,383,372    26,807,978    16,704,748 

 

4

 

 

CYCURION, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   June 30, 2025   June 30, 2024 
   For the Six Months Ended 
   June 30, 2025   June 30, 2024 
Cash flows from operating activities:          
Net loss  $(15,538,900)  $(6,381)
Adjustments to reconcile net loss to net cash used in operating activities:          
Stock based compensation   10,534,777    10,000 
Amortization of debt discount   213,036    - 
Depreciation of property and equipment   3,489    4,394 
Amortization of software development costs   17,083    - 
Loss on debt settlement, net   766,330    - 
Finance expense   100,000    - 
Changes in assets and liabilities:          
Accounts receivable, net and other receivables   (1,478,433)   (1,267,911)
Prepaid expenses and other current assets   45,204    16,050 
Accounts payable and accrued liabilities   (965,708)   393,435 
Net cash used in operating activities   (6,303,122)   (850,413)
Cash flows from investing activities:          
Cash acquired on acquisition of subsidiary   34,983    - 
Issuance of promissory notes   -    (354,000)
Purchase of plant and equipment   (174,000)   (238,000)
Cash withdrawn from Trust Account in connection with redemption   1,001,216    - 
Release of Trust Account to Company’s bank account   833,324    - 
Net cash provided by/(used in) investing activities   1,695,523    (592,000)
Cash flows from financing activities:          
Proceeds from exercise of warrants   3,664,671    - 
Redemption of common stock subject to redemption   (1,001,216)   - 
Proceeds from private placement   -    1,000,000 
Proceeds from capital raise   265,504    - 
Net proceeds from line of credit   (12,900)   39,181 
Repayment of bank borrowings   (155,114)   (6,503)
Proceeds from convertible notes payable   2,376,500    - 
Proceeds from notes payable   513,200    - 
Repayments of notes payable   (70,000)   - 
Net cash provided by financing activities   5,580,645    1,032,678 
Net increase/(decrease) in cash and cash equivalents   973,046    (409,735)
Cash and cash equivalents, beginning of period   40,790    607,869 
Cash and cash equivalents, end of period  $1,013,836   $198,134 

 

5

 

 

CYCURION, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)

 

   Shares      Shares      Shares      Shares      Shares      Shares         Shares           Shares                   
   Common stock subject to possible redemption   Series A Convertible Preferred Stock   Series B Convertible Preferred Stock   Series C Convertible Preferred Stock   Series D Convertible Preferred Stock   Series E Convertible Preferred Stock    Series G
Convertible
Preferred Stock
   Common Stock   Additional           Non-   Total 
   Shares   Amount ($)   Shares   Amount ($)   Shares   Amount ($)   Shares   Amount ($)   Shares   Amount ($)   Shares   Amount ($)    Shares     Amount ($)    Shares   Amount ($)   Paid-In Capital   Accumulated Deficit   Total   Controlling Interest   Stockholders’ Equity 
Balance as of December 31, 2024   173,879   $1,917,309    -   $-    3,000   $-    4,851   $-    -   $-    -   $-      -     $ -     10,592,607   $1,059   $6,670,060   $(3,203,361)  $3,467,758   $-   $3,467,758 
Common stock redeemed (Mezzanine Equity)   (94,896)   (1,001,216)   -    -    -    -    -    -    -    -    -    -      -       -     -    -    -    -    -    -    - 
Release of common stock subject to redemption   (78,983)   (916,093)   -    -    -    -    -    -    -    -    -    -      -       -     78,983    8    916,085    -    916,093    -    916,093 
Series A preferred stock in exchange of Series A Preferre Stock categorized as liability   -    -    106,816    11    -    -    -    -    -    -    -    -      -       -     -    -    1,391,165    -    1,391,176    -    1,391,176 
Series D preferred stock in exchange of convertible notes   -    -    -    -    -    -    -    -    6,666,666    667    -    -      -       -     -    -    3,332,668    -    3,333,335    -    3,333,335 
Common stock issued for conversion of Series B and D Preferred Stock   -    -    -    -    (2,999)   -    -    -    (6,516,666)   (652)   -    -      -       -     12,515,319    1,252    (600)   -    -    -    - 
Common stock issued for exercise of warrants   -    -    -    -    -    -    -    -    -    -    -    -      -       -     7,044,917    704    3,309,217    -    3,309,921    -    3,309,921 
Common stock issued for business combination costs   -    -    -    -    -    -    -    -    -    -    -    -      -       -     750,000    75    8,999,925    -    9,000,000    -    9,000,000 
Common stock issued for settleemnt of liability   -    -    -    -    -    -    -    -    -    -    -    -      -       -     78,803    8    945,628    -    945,636    -    945,636 
Common stock issued for employment agreement   -    -    -    -    -    -    -    -    -    -    -    -      -       -     500,000    50    249,950    -    250,000    -    250,000 
Acquisiton of subsidiary   -    -    -    -    -    -    -    -    -    -    51    -      -       -     508,141    51    509,020    -    509,071    -    509,071 
Excise tax liability arising from redemption of Class A shares   -    -    -    -    -    -    -    -    -    -    -    -      -       -     -    -    -    (10,012)   (10,012)   (3,464,218)   (3,474,230)
Net loss   -    -    -    -    -    -    -    -    -    -    -    -      -       -     -    -    -    (10,248,486)   (10,248,486)   -    (10,248,486)
Balance as of March 31, 2025   -    -    106,816    11    1    -    4,851    -    150,000    15    51    -      -       -     32,068,770    3,207    26,323,118    (13,461,859)   12,864,492    (3,464,218)   9,400,274 
Series G preferred stock in exchange of convertible notes and promissory notes   -    -    -    -    -    -    -    -    -    -    -    -      3,318       -     -    -    4,183,891    -    4,183,891    -    4,183,891 
Common stock issued for exercise of warrants   -    -    -    -    -    -    -    -    -    -    -    -      -       -     3,209,000    321    354,429    -    354,750    -    354,750 
Common stock issued for settleemnt of liability   -    -    -    -    -    -    -    -    -    -    -    -      -       -     2,742,607    275    1,028,203    -    1,028,478    -    1,028,478 
Common stock issued for employment agreement   -    -    -    -    -    -    -    -    -    -    -    -      -       -     683,465    68    256,231    -    256,299    -    256,299 
Common Stock Issued - Equity Line   -    -    -    -    -    -    -    -    -    -    -    -      -       -     1,150,000    115    265,389    -    265,504    -    265,504 
Acquisiton of subsidiary   -    -    -    -    -    -    -    -    -    -    -    -      -       -     500,141    50    250,021    -    250,071    -    250,071 
Net loss   -    -    -    -    -    -    -    -    -    -    -    -      -       -     -    -    -    (5,188,755)   (5,188,759)   (101,659   (5,290,414)
Balance as of June 30, 2025   -   $-    106,816   $11    1   $-    4,851   $-    150,000   $15    51   $-      3,318     $ -     40,353,983   $4,036   $32,661,282   $(18,650,614)  $14,014,730   $(3,565,877)  $10,448,853 

 

   Shares   Amount ($)   Shares   Amount ($)  

Capital

  

Deficit

   Equity 
   Series B Convertible Preferred Stock   Common Stock  

Additional

Paid-In
   Accumulated  

Total

Stockholders’

 
   Shares   Amount ($)   Shares   Amount ($)  

Capital

  

Deficit

   Equity 
Balance as of December 31, 2023   2,000   $2,000,000    14,968,215   $14,969   $7,664,104   $(4,432,962)  $3,246,111 
Board compensation   -    -    -    -    10,000    -    10,000 
Net loss   -    -    -    -    -    (312,475)   (312,475)
Balance as of March 31, 2024   2,000    2,000,000    14,968,215    14,969    7,674,104    (4,745,437)   2,943,636 
Series B preferred stock and warrants issued   1,000    1,000,000    -    -    -    -    - 
Net income   -    -    -    -    -    306,094    306,094 
Balance as of June 30, 2024   3,000   $3,000,000    14,968,215   $14,969   $7,674,104   $(4,439,343)  $3,249,730 

 

6

 

 

CYCURION, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

1. ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Description of Business

 

Cycurion, Inc (f/k/a KAE Holdings, Inc.; f/k/a Cyber Secure Solutions, Inc.; the “Company”, “Cycurion”, “we”, “us” or “our”) was incorporated on October 12, 2017, in the state of Delaware. Through its subsidiaries, the Company provides premier information technology security solutions. The Company continually strives to deliver top-notch services in the areas of risk management, cybersecurity, information assurance, systems engineering and help desk solutions. The Company is headquartered in McLean, Virginia. On July 14, 2020, the Company changed its corporate name from KAE Holdings, Inc. to Cyber Secure Solutions, Inc., and, on February 24, 2021, to Cycurion, Inc.

 

The Company has one first-tier wholly-owned subsidiary, Cycurion Sub, Inc. (formerly Cycurion, Inc., until February 14, 2025), and three indirectly wholly-owned second-tier subsidiaries: (i) Axxum Technologies LLC (“Axxum”), a Virginia limited liability company formed in December 2006, (ii) Cloudburst Security LLC (“Cloudburst”), a Virginia limited liability company formed in January 2007, and (iii) Cycurion Innovation, Inc., a Delaware corporation formed in September 2021 (“Cycurion Innovation”), in connection with our acquisition of assets from Sabres Security Ltd. (“Sabres”), a leading Israeli-based cyber security provider.

 

Business Combination

 

On February 14, 2025, we completed the business combination and transactions (the “Business Combination”) as set forth in an Agreement and Plan of Merger, dated November 21, 2022, as amended on April 26, 2024, December 31, 2024 and February 13, 2025 (the “Merger Agreement”), by and among Western Acquisition Ventures Corp. (“Western”), Western Acquisition Merger Inc., a Delaware corporation and a wholly-owned subsidiary of Western (“Merger Sub”), and Cycurion Sub, Inc., a Delaware corporation formerly known as Cycurion, Inc. (“Cycurion Sub”). As contemplated by the Merger Agreement, Merger Sub merged with and into Cycurion Sub with Cycurion Sub as surviving the merger as a wholly-owned subsidiary of Western. In addition, in connection with the consummation of the Business Combination, Western was renamed “Cycurion, Inc.”

 

On February 14, 2025, the parties completed the Business Combination. As a result of the Business Combination, each ordinary share of Cycurion Sub was cancelled and converted into shares of Company common stock, on the terms set forth in the Merger Agreement. Pursuant to the terms of the Merger Agreement, the aggregate number of shares of Company common stock that was delivered as consideration in the Business Combination was capped at 15,000,000 shares. 680,875 Series A warrants, 6,000,000 Series B warrants, 7,272,728 Series D warrants , 270,171 common stock warrants, 472,813 shares of common stock issued in connection with the Series D private placement, 500,000 shares of common stock issued to A.G.P./Alliance Global Partners (“A.G.P.”), 250,000 shares of common stock issued to Seward & Kissel LLP and 78,803 shares of common stock issued to Baker & Hostetler LLP.

 

The Business Combination has been accounted for as a reverse recapitalization in accordance with U.S. GAAP because Cycurion is the operating company and has been determined to be the accounting acquirer under Financial Accounting Standards Board’s Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”), while Western is a blank check company.

 

Under the reverse recapitalization model, the Business Combination was treated as Cycurion issuing equity for the net assets of Western, with no goodwill or intangible assets recorded.

 

While Western was the legal acquirer in the Business Combination, because Cycurion, prior to the Business Combination (“Predecessor Cycurion”), was deemed the accounting acquirer, the historical financial statements of Predecessor Cycurion became the historical financial statements of the combined company upon the consummation of the Business Combination. As a result, the financial statements reflect (i) the historical operating results of Predecessor Cycurion prior to the Business Combination; (ii) the combined results of Western and Predecessor Cycurion following the closing of the Business Combination; (iii) the assets and liabilities of Predecessor Cycurion at their historical cost; and (iv) Cycurion’s equity structure for all periods presented.

 

In accordance with the applicable guidance, the equity structure has been retroactively restated in all comparative periods up to the Closing Date, to reflect the number of shares of the Company’s common stock issued to Predecessor Cycurion common stockholders in connection with the Business Combination. As such, the shares and corresponding capital amounts and earnings per share related to Predecessor Cycurion prior to the Business Combination have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination.

 

7

 

 

Going Concern

 

The accompanying financial statements have been prepared in conformity with generally accepted accounting principles (“GAAP”) in the United States, which contemplates continuation of the Company on a going concern basis. The going concern basis assumes that assets are realized, and liabilities are settled in the ordinary course of business at amounts disclosed in the financial statements. As of June 30, 2025, there was substantial doubt regarding the Company’s ability to continue as a going concern, as the Company had a net working capital deficit and an accumulated deficit resulting from substantial losses incurred during the three and six months ended June 30, 2025 and from prior periods. The Company’s ability to continue as a going concern depends upon its ability to market and sell its products to generate positive operating cash flows. As of June 30, 2025, the Company had an accumulated deficit of $18.7 million and a working capital deficit of $14.4 million. In addition, the Company had a net cash outflow of $6.3 million from operating activities during the six months ended June 30, 2025. These circumstances continued to give rise to substantial doubt as to whether the Company will be able to continue as a going concern and did not alleviate the doubt outstanding from 2024.

 

Management’s plan is to continue improving operations to generate positive cash flows and register shares of its common stock in order to undertake a public offering to raise additional capital. Management believes that the valuation and liquidity brought by a public offering of its securities will allow holders of convertibles notes, and convertible preferred stockholders the mechanism to convert their securities into common stock that will reduce the Company’s overall leverage and debt service requirement. If the Company is not able to continue generating positive operating cash flows, and raise additional capital, there is the risk that the Company may become insolvent.

 

Nasdaq Communications

 

On April 9, 2025, Cycurion received a written notice received from the Listing Qualifications Department of Nasdaq stating that, for the prior 30 consecutive business days, the closing bid price of the Company’s common stock had been below the minimum of $1 per share required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The notification letter stated that the Company would be afforded 180 calendar days (until October 6, 2025) to regain compliance. In order to regain compliance, the closing bid price of the Company’s common stock must be at least $1 for a minimum of ten consecutive business days. The notification letter also stated that, in the event the Company does not regain compliance within the initial 180-day period, the Company may be eligible for an additional 180-day period. If the Company is not eligible for the additional 180-day period, or if it appears to the Nasdaq staff that the Company will not be able to cure the deficiency, the Nasdaq Listing Qualifications Department will provide notice after the end of the initial 180-day period that the Company’s securities will be subject to delisting. The Nasdaq notification has no effect at this time on the listing of the Company’s common stock.

 

On April 11, 2025, we received two letters from the Nasdaq Listing Qualifications Department, each addressing a separate compliance deficiency of the Company under the Nasdaq Listing Rules. The first letter from the Nasdaq Listing Qualifications Department notified us of our non-compliance with Nasdaq Listing Rule 5450(b)(2)(A), which requires a company such as ours whose securities are listed on The Nasdaq Global Market under the “Market Value Standard” to maintain a minimum Market Value of Listed Securities (an “MVLS”) of $50,000,000. The deficiency was triggered by our MVLS having closed below the minimum level for a period of 30 consecutive business days. Under Nasdaq Listing Rule 5810(c)(3)(C), we are entitled to a 180-day period, ending on October 8, 2025, to rectify the deficiency. In order to do so, we must achieve and maintain an MVLS of $50,000,000 or more for at least 10 consecutive business days. Failure to regain compliance within the 180-day period would result in the delisting of our securities from Nasdaq, although we would have the right to appeal such a delisting to a Nasdaq hearings panel.

 

The second letter informed us of our deficiency in complying with Nasdaq Listing Rule 5450(b)(2)(C), which requires a minimum Market Value of Publicly Held Shares (an “MVPHS”) of $15,000,000 for continued listing on the Nasdaq Global Market under the “Market Value Standard”. This deficiency was caused by our MVPHS having fallen below the minimum threshold for the prior 30 consecutive business days. Under Nasdaq Listing Rule 5810(c)(3)(D), we have 180 calendar days, or until October 8, 2025, to regain compliance, which we can achieve if its MVPHS closes at or above $15,000,000 for at least 10 consecutive business days. Failure to regain compliance within that 180-day period would result in the delisting of our securities from Nasdaq, subject to our right to appeal to a Nasdaq hearings panel.

 

On May 22, 2025, Cycurion received written notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the “Form 10-Q”), as described more fully in the Company’s Form NT 10-Q Notification of Late Filing (the “Form NT 10-Q”) filed with the U.S. Securities and Exchange Commission (“SEC”) on May 15, 2025. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC. On June 6, 2025, Cycurion filed its Form 10-Q for the period ended March 31, 2025.

 

8

 

 

Restricted Cash

 

In accordance with the trust agreement between Western and Equiniti Trust Company, LLC, dated January 11, 2022, the Company is permitted to withdraw interest from the trust account (the “Trust Account”) to pay its tax obligations, including federal income taxes and state franchise taxes. The balance of this withdrawal would be presented in restricted cash, but as of June 30, 2025 there are no amounts in restricted cash.

 

2. SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited consolidated condensed financial statements are presented in conformity with generally accepted accounting principles in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP for audited financial statements. In the opinion of management, the unaudited consolidated condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. The interim results for the three and six months ended June 30, 2025 are not necessarily indicative of the results to be expected for the year ended December 31, 2025 or for any future interim periods.

 

The accompanying unaudited consolidated condensed financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto, included in the Annual Report on Form 10-K filed with the SEC on April 17, 2025.

 

Principles of Consolidation

 

These financial statements include the accounts of Cycurion, Inc. (f/k/a KAE Holdings, Inc.; f/k/a Cyber Secure Solutions, Inc.) and its wholly owned subsidiaries: Axxum, Cloudburst, Cycurion Innovation and SLG Innovation Inc. (“SLG”). All significant inter-company balances, fees, and expenses have been eliminated in consolidation.

 

Segment Information

 

Our Chief Executive Officer (“CEO”) is the chief operating decision maker who reviews financial information on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, we determined we operate in a single reporting segment.

 

Our CEO assesses performance and decides how to allocate resources primarily based on consolidated net income, which is reported on our Consolidated Statements of Operations. Total assets on the Consolidated Balance Sheets represent our segment assets.

 

Reclassification

 

Certain amounts have been reclassified to improve the clarity and comparability of the financial statements. These reclassifications had no impact on previously reported total assets, liabilities, equity, net income (loss), or cash flows for any periods presented.

 

Emerging Growth Company

 

The Company is an emerging growth company as defined in Section 102(b)(1) of the Jumpstart Our Business Start-ups Act of 2012 (the “JOBS Act”) which exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies, but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised, and it has different application dates for public or private companies. The Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

 

9

 

 

This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of estimates

 

The preparation of financial statements in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and disclosures regarding contingent liabilities at the date of the financial statements. These estimates may affect the reported amounts for certain revenues and expenses incurred during the reporting period; actual results may materially differ from these estimates.

 

Cash and Cash Equivalents and Restricted Cash

 

Cash and cash equivalents include cash on hand, deposits in banks, and any investments with maturities with less than three months from inception to maturity.

 

Common Stock Subject to Possible Redemption

 

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC 480. Shares of common stock subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s shares of common stock sold in the initial public offering of Western feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events.

 

Table 2.1: Rollforward of Common Stock Subject to Possible Redemption
   Number of Shares   Amount 
Common stock subject to possible redemption as of December 31, 2024   173,879   $1,917,309 
Less:          
Redemption   (94,896)   (1,001,216)
Release of common stock subject to redemption   (78,983)   (916,093)
Common stock subject to possible redemption as of June 30, 2025   -   $- 

 

Accounts Receivable

 

Accounts receivable is stated at the original amount less an allowance for credit losses.

 

Accounts receivable is recognized in the period when the Company has provided services to its customers and when its right to consideration is unconditional. ASC 326 introduces an approach based on expected losses to estimate the allowance for credit losses, which replaces the previous incurred loss impairment model. The Company’s estimation of allowance for credit losses considers factors such as historical credit loss experience, age of receivable balances, subsequent collection, current market conditions, reasonable and supportable forecasts of future economic conditions.

 

The Company evaluates its accounts receivable for expected credit losses on a regular basis. The Company maintains an estimated allowance for credit losses to reduce its accounts receivable to the amount that it believes will be collected. The Company considers factors in assessing the collectability of its receivables, such as the age of the amounts due, the customer’s payment history, credit-worthiness and other specific circumstances related to the accounts. If there is strong evidence indicating that the accounts receivable is likely to be unrecoverable, the Company also makes specific allowance in the period in which a loss is determined to be probable. Accounts receivable balances are written off after all collection efforts have been exhausted.

 

The Company also assessed the creditworthiness and solvency of its customers as of June 30, 2025 and December 31, 2024 and has determined that those customers were unlikely not to settle their balances in full; accordingly, as of June 30, 2025 and December 31, 2024, the Company’s estimated allowance for credit losses was both zero.

 

10

 

 

Property, Plant, and Equipment

 

Property and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation and amortization is recorded over the assets’ estimated useful lives using the straight-line method, which is three to five years for furniture and equipment, one year for capital leases and three years for software. Leasehold improvements are amortized over the shorter of their useful life or the remaining term of the lease. Repairs and maintenance costs are expensed as incurred.

 

Goodwill

 

Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable assets acquired in a business combination. Goodwill is reviewed for impairment annually during the fourth quarter of each fiscal year, or more frequently if impairment indicators arise. The review of goodwill impairment consists of either using a qualitative approach to determine whether it is more likely than not that the fair value of the assets is less than their respective carrying values or a one-step quantitative impairment test. In performing the qualitative assessment, we consider many factors in evaluating whether the carrying value of goodwill may not be recoverable. If, based on the results of the qualitative assessment, it is concluded that it is not more likely than not that the fair value of a reporting unit exceeds its carrying value, additional quantitative impairment testing is performed. The quantitative test requires that the carrying value of each reporting unit be compared with its estimated fair value. If the carrying value of a reporting unit is greater than its fair value, a goodwill impairment charge will be recorded for the difference (up to the carrying value of goodwill). Fair value is generally determined using a discounted cash flow analysis. During the three and six months ended June 30, 2025 and 2024, no impairment of goodwill was recognized.

 

Software Development Costs

 

The Company is undergoing new Software as a Service (“SaaS”) product development based on an acquired SaaS platform in previous years, which has not been utilized in its original form. Cost from the acquired SaaS platform, functionalities and modules and the redesigned features of the distinct new SaaS product are accounted for under ASC 985-20 (Costs of Software to Be Sold, Leased, or Marketed). Development costs were capitalized as “Software Development in Progress” after achieving technological feasibility.

 

Accounting for long-lived assets

 

The Company annually reviews its long-lived assets for impairment or whenever events or changes in circumstances indicate that the carrying amount of assets may not be recoverable. Impairment may be the result of becoming obsolete from a change in the industry or new technologies. Impairment is present if the carrying amount of an asset is less than its undiscounted cash flows to be generated.

 

If an asset is considered impaired, a loss is recognized based on the amount by which the carrying amount exceeds the fair market value of the asset. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.

 

Bank loans

 

The Company accounts for borrowings from banks as either current or long-term borrowings. Origination and closing costs for long term borrowings are accounted for using the effective interest method and accreted to the Company’s outstanding balances owed over the life of the long-term loan, and the related interest expense is recognized to the results of operations.

 

Revenue recognition

 

The Company adopted ASC Topic 606, Revenue from Contracts with Customers. Revenue from contracts with customers is recognized using the following five steps:

 

  1. Identify the contract(s) with a customer;
  2. Identify the performance obligations in the contract;
  3. Determine the transaction price;
  4. Allocate the transaction price to the performance obligations in the contract; and
  5. Recognize revenue when (or as) the entity satisfies a performance obligation.

 

In applying ASC 606, the Company will recognize revenue when the Company has negotiated and formalized the terms of the transaction in the form of written contracts with their customers that set forth the sales price, the scope of services to be delivered by professional technology infrastructure and cyber engineers measured in hours, accompanied by hourly billing rates, and payment terms; typically, the performance obligations in the contract are the delivery of service hours; when the Company has obtained evidence that the service has been delivered and the performance obligations have been fulfilled, it will record revenue and either recognize an asset such as accounts receivable or decrease deferred revenue from its liabilities.

 

11

 

 

Management has determined that its services business can be segregated into four lines of business. Each line of business has its own methodology for recognizing revenue.

 

Advisory Consulting

 

The Company enters into service agreements with customers that will set forth the responsibilities of both parties, including the type of service to de delivered, the timing of the delivery of those services, and the associated price per unit for such services. The unit of measure in the agreement is typically hours. The advisory consulting services represent a single performance obligation, as they constitute a series of distinct hourly services that are substantially the same and transferred to the customer over time. The revenue from advisory service agreement will also set forth the timing of payments by the customers which is typically between 60 and 90 days from the date that an invoice is issued to the customer. The Company issues invoices when management has received acknowledgment from the customer that it has rendered service as measured in hours to the customer. As a practical matter, the Company continuously delivers service to customers, and the customer receives benefits from those services over time. The revenue advisory consulting is recognized over time as services are rendered, based on contractual hourly rates, and when the Company has received the aforementioned acknowledgement from its customers that service has been rendered related to hours accumulated over period of time, such as a week, or two weeks, or a month, which is determined on a customer by customer basis. The Company’s contracts do not include terms for returns, or warranties, or guarantees, or rebates, or discounts on the services rendered. The company also enters into annual contracts with customers to provide ongoing advisory and consulting services. Services are delivered continuously over the contract term and customers are billed periodically. The annual service contract represents a single performance obligation because the services are a series of distinct, substantially similar acts that are inseparable and transferred over time. Revenue is recognized over time straight-line over the contract term.

 

Managed Security Service Practice (MSSP)

 

Management has determined that its managed security service practice is a bundle of cybersecurity software tools, and expert 24x7x365 monitoring and breach resolution service that is accounted for as a single performance obligation that is delivered over time which is typically a month; the components of the bundle have individual commercial value; however, management believes assigning stand-alone value to each component is impractical because each component would not be able to be fully implemented or utilized if not packaged with the other components; therefore, management believes the MSSP can only be sold as a bundle package over time. At the time that the Company recognizes revenue it is has either already received funds in advance from its customer, or it is reasonably assured that it will collect funds from its customer; in the event that funds that are received in advance, they are accounted for as contract liabilities in the deferred revenue account until the Company fulfills the performance obligation; a majority of the Company’s contracts call for the Company to first deliver service and collect fees thereafter; the Company typically receives payment for these contracts within thirty to ninety days of delivery of service. The Company does not sell monitoring time, security software-tools, and breach resolution as stand-alone services, as the customer would not receive the benefits of these items if they were not sold as an integrated package. The cybersecurity needs to monitor the customer cybersecurity environment regularly, stay up to date on cyberthreats and solutions, maintain its software tools, and then address threats identified, or rectify situations when customer environments have been breached. It is not practical or viable to sell these components separately, as customers expect comprehensive solutions. While the components are separately identifiable, management does not believe they could market the components individually. The Company’s management does not believe their customers can benefit from the individual components alone, and there are not readily available resources in the market that can be obtained to make those components viable. The continuous monitoring allows the Company to identify and either neutralize and or rectify breaches by having up to the minute first-hand information, and the tools allow the Company to implement solutions rapidly; the absence all of the components would render the solutions and service offering significantly devalued and non-competitive in the marketplace.

 

The Company believes MSSP meets the criteria to combine the goods and services under a single performance obligation. The Company believes combined integrated solution is delivered continuously over a period of time; in accordance with the terms of the contract between the Company and its customers, the Company receives prepayments in advance from its customers, and recognizes those payments to revenues over a period of time, which is typically each month.

 

Managed Service Provider (MSP)

 

The Company’s managed service provider (MSP) service offering is the provision of IT infrastructure support to customers, specifically in the areas of desktop support, on-site troubleshooting, and cloud-based network infrastructure troubleshooting. This service is accounted for as a single performance obligation that is delivered over time, which is typically a month; At the time that the Company recognizes revenue, it either already received funds in advance from its customer, or it is reasonably assured that it will collect funds from its customer; in the event that funds that are received in advance, they are accounted for as contract liabilities in the deferred revenue account until the Company fulfills the performance obligation; a majority of the Company’s contracts call for the Company to first deliver service and collect fees thereafter; the Company typically receives payment for these contracts within thirty to ninety days of delivery of service.

 

12

 

 

MSP requires the integration of tools and labor in order for a customer to receive any benefit from the services provided. The Company refers to the guidance in ASC 606-10-25-19 to provide an analysis regarding this accounting recognition of this integrated service. Under MSP, the customer cannot receive any benefit purely from labor or individual software tools as a stand-alone service. The tools that the Company deploys require engineers to decipher results and develop solutions to problems during the service period covered in a contract.

 

While components can be separately identified, they must be used in conjunction with each other to serve the Company’s customers. The Company must continuously make available support engineers to customers whenever they need support and troubleshooting. The service includes remote resolution of issues or going onsite to customer locations to solve problems. The Company’s contracts with customers require the Company to have these resources available during the length of the contract; therefore, these services are continuously delivered as a service over time; accordingly, the Company recognizes revenue for such MSP contract on a monthly basis.

 

Software as a service (SaaS)

 

Management has determined that its software as a service is a suite of cybersecurity tools that are delivered either remotely or on customer premises. The service is delivered on a monthly basis. The cybersecurity tools are typically sold as a package; however, the individual components of the suite of tools can either be sold individually or bundled together. Nevertheless, if they are sold individually, or as a bundle, they are all delivered over time; accordingly, the Company recognizes revenue over time, which is typically monthly; At the time that the Company recognizes revenue it is has either already received funds in advance from its customer, or it is reasonably assured that it will collect funds from its customer; in the event that funds that are received in advance, they are accounted for as contract liabilities in the deferred revenue account until the Company fulfills the performance obligation ; a majority of the Company’s contracts call for the Company to first deliver service and collect fees thereafter; the Company typically receives payment for these contracts within thirty to ninety days of delivery of service.

 

The Company’s SaaS is delivered continuously over time; it is a subscription service where the Company provisions a suite of security software tools to its customers accessed via the internet that allows the customers to protect themselves from cyber-attacks using multiple tools within the suite. This subscription service is recognized to revenue monthly.

 

                 
Table 2.2: Disaggregated Revenue
   For the Three Months Ended   For the Six Months Ended 
   June 30, 2025   June 30, 2024   June 30, 2025   June 30, 2024 
Advisory consulting  $3,848,688   $4,979,292   $7,684,102   $9,199,854 
Managed security service practice (MSSP)   35,555    18,348    67,068    36,969 
Software as a service (Saas)   3,672    3,672    6,795    7,344 
Revenue  $3,887,915   $5,001,312   $7,757,965   $9,244,167 

 

Cost of revenue

 

Cost of revenue primarily consists of compensation expenses for program personnel, and the fringe benefits associated with this compensation, subcontractor costs, and other direct expenses incurred to deliver services to customers.

 

Selling, General, and Administrative Expenses

 

Selling, general and administrative expenses are expensed as incurred.

 

Income taxes

 

The Company accounts for income tax using an asset and liability approach and allows for recognition of deferred tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future realization is uncertain.

 

13

 

 

Earnings per share

 

The Company computes earnings per share (“EPS”) in accordance with ASC Topic 260, “Earnings per share”. Basic EPS is measured as the income or loss available to common stockholders divided by the weighted average number of common shares outstanding for the period. Diluted EPS is similar to basic EPS but presents the dilutive effect on a per-share basis of potential common shares (e.g., convertible securities, options, and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

 

As of June 30, 2025, common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive (see Note 19).

 

Commitments and contingencies

 

Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.

 

Comprehensive income

 

Comprehensive income is defined to include all changes in equity except those resulting from investments by owners and distributions to owners. Among other disclosures, all items that are required to be recognized under current accounting standards as components of comprehensive income are required to be reported in a financial statement that is presented with the same prominence as other financial statements. The Company’s current component of other comprehensive income includes the foreign currency translation adjustment and unrealized gain or loss.

 

Accounting for Warrants

 

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the instruments are free standing financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own common shares and whether the instrument holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, was conducted at the time of warrant issuance and as of each subsequent period end date while the instruments are outstanding. Management has concluded that the Public Warrants, Private Placement Warrants, and all other warrants issued qualify for equity accounting treatment.

 

Recently Issued Accounting Pronouncements

 

In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

 

In March 2024, the FASB issued ASU 2024-02 “Codification Improvements – Amendments to Remove References to the Concepts Statements” (“ASU 2024-02”), which contains amendments to the Codification to remove references to various FASB Concepts Statements. In most instances, the references are extraneous and not required to understand or apply the guidance. Generally, ASU 2024-02 is not intended to result in significant accounting changes for most entities. ASU 2024-02 is effective for the Company for fiscal years beginning after December 15, 2024. The Company does not expect this update to have a material impact on its financial statements.

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires, among other things, additional disclosures primarily related to the income tax rate reconciliation and income taxes paid. The expanded annual disclosures are effective for our year ending December 31, 2025. The Company is currently evaluating the impact that ASU 2023-09 will have on the consolidated financial statements and whether the Company will apply the standard prospectively or retrospectively.

 

The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

 

14

 

 

3. ACCOUNTS RECEIVABLE, NET

 

         
Table 3: Details of Accounts Receivable, Net
   June 30, 2025   December 31, 2024 
Accounts receivable  $4,118,888   $10,353,708 
Allowance for credit losses   -    - 
Accounts receivable, net  $4,118,888   $10,353,708 

 

During both the three and six months ended June 30, 2025 and 2024, the Company had no write-offs of any outstanding receivables.

 

4. PROPERTY AND EQUIPMENT, NET

 

Table 4: Details of Property and Equipment, Net
   June 30, 2025   December 31, 2024 
   Gross Carrying Amount   Accumulated Depreciation and Amortization   Net Carrying Amount   Gross Carrying Amount   Accumulated Depreciation and Amortization   Net Carrying Amount 
Equipment  $125,546   $(124,550)  $996   $125,546   $(121,869)  $3,677 
Furniture and fixtures   26,339    (19,624)   6,715    26,339    (19,396)   6,943 
Leasehold improvements   62,721    (62,721)   -    62,721    (62,721)   - 
Capital lease   23,004    (19,897)   3,107    23,004    (19,897)   3,107 
Software   13,500    (7,486)   6,014    13,500    (6,906)   6,594 
Total  $251,110   $(234,278)  $16,832   $251,110   $(230,789)  $20,321 

 

During the three and six months ended June 30, 2025 and 2024, the Company recorded immaterial amounts of depreciation expense in cost of revenue and selling, general and administrative expenses.

 

5. SOFTWARE DEVELOPMENT COSTS

 

In 2024, the Company reclassed software development costs from property and equipment to software development costs. The Company continuing incurs costs to develop new modules, functionalities, and integrations on previous purchased SaaS platform in order to develop a new product with differentiated offering. As of June 30, 2025, the SaaS platform is still undergoing development stage and not ready for external sales. No amortization has been recorded during the three and six months ended June 30, 2025 and 2024.

 

In 2024, the Company reclassed a part of software from property and equipment to software development costs.

 

                 
Table 5: Capitalized Software Development Costs
   For the Three Months Ended   For the Six Months Ended 
   June 30, 2025   June 30, 2024   June 30, 2025   June 30, 2024 
Capitalized software development costs  $104,000   $132,999   $174,000   $238,000 

 

15

 

 

6. INTANGIBLE ASSETS

 

Table 6.1: Details of Intangible Assets, Net
   June 30, 2025   December 31, 2024 
   Gross Carrying Amount   Accumulated Depreciation and Amortization   Net Carrying Amount   Gross Carrying Amount   Accumulated Depreciation and Amortization   Net Carrying Amount 
Contractual relationship  $66,361   $(66,361)  $-   $66,361   $(66,361)  $- 
Implementation   28,099    (28,099)   -    28,099    (28,099)   - 
Software   100,000    (92,083)   7,917    100,000    (75,000)   25,000 
Intangible assets  $194,460   $(186,543)  $7,917   $194,460   $(169,460)  $25,000 

 

                 
Table 6.2: Details of Intangible Asset Amortization
   For the Three Months Ended   For the Six Months Ended 
   June 30, 2025   June 30, 2024   June 30, 2025   June 30, 2024 
Amortization expense, presented in SG&A  $8,750   $-   $17,083   $- 

 

7. BUSINESS COMBINATION

 

SLG Innovation, Inc.

 

SLG is a technology services firm with operations and client contracts deemed to be strategically complementary to the Company’s existing business and long-term growth objectives. As of December 31, 2020, the Company had initiated discussions regarding the potential acquisition of SLG and had advanced a non-refundable deposit of $1,401,923 for cash advances, loans, capitalized transaction costs and accounts receivable arising from prior business dealings with SLG. On May 13, 2021, the Company entered into an agreement to acquire substantially all of SLG’s assets and certain liabilities, which included a termination right exercisable at the Company’s sole discretion prior to December 31, 2021. This agreement was subsequently amended to limit the acquisition to certain specified assets, primarily identifiable sales contracts.

 

As of December 31, 2024, the refundable deposit had increased to $2,000,000, comprising $561,808 in cash advances and loans, $20,000 in due diligence costs, and $1,418,192 in accounts receivable.

 

On April 29, 2023, the Company and SLG executed a unidirectional letter of intent (“SLG LOI”), which bound SLG to the transaction but did not obligate the Company. The SLG LOI provided that, unless terminated by the Company on or before April 30, 2024, the Company would proceed to acquire SLG or substantially all of its assets and liabilities through a structure to be finalized. The agreed-upon valuation included the $2,000,000 receivable, $2,136,445 in SLG payables to RCR Technology Corporation (excluding payables incurred within 90 days prior to closing), and 996,355 shares of the Company’s capital stock.

 

In connection with the SLG transaction, the Company also entered into a separate unidirectional letter of intent with RCR (“RCR LOI”) on April 29, 2023, under which the Company would acquire SLG’s payables owed to RCR, subject to the closing of the SLG transaction. Consideration for the RCR transaction was to be settled in the form of Company shares, as specified in the RCR LOI.

 

On March 31, 2025, the company entered into a Management Services Agreement and a Release agreement (the “Agreement”) to acquire certain assets and assumed certain liabilities to acquire 51% of equity interest in SLG. The total purchase consideration related to acquisition of SLG consisted primarily of:

 

(a)prepaid deposit of $2,000,000;
   
(b)1,008,282 shares of common stock having par value of $0.0001 per share;
   
(c)51 shares of Series E Preferred stock with a face value of $10,000 and conversion price of $1.00; and
   
(d)$10,814,147 of accounts receivable in Cycurion owing from SLG

 

16

 

 

The Company has determined that the SLG acquisition constitutes a business combination as defined by ASC 805, Business Combinations (“ASC 805”). ASC 805 establishes principles and requirements as to how the acquirer of a business recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed and any non-controlling interest in the acquiree. The assets acquired and liabilities assumed were recognized provisionally in the accompanying consolidated balance sheets at their estimated fair values as of March 31, 2025, and adjusted in the second quarter of 2025. The initial accounting for the business combination is not complete as the Company is in the process of obtaining additional information for the valuation of acquired assets and liabilities, if any. The provisional amounts are subject to change to the extent that additional information is obtained about the facts and circumstances that existed as of the acquisition date. Under U.S. GAAP, the measurement period shall not exceed one year from the acquisition date and the Company will finalize these amounts no later than March 31, 2026. The estimated fair values as of the acquisition date are based on information that existed as of the acquisition date. During the measurement period the Company may adjust provisional amounts recorded for assets acquired and liabilities assumed to reflect new information that the Company has subsequently obtained regarding facts and circumstances that existed as of the acquisition date. The results of operations for SLG are included in the consolidated results of Cycurion, Inc. starting April 1, 2025.

 

             
Table 7: SLG Valuation
   Initial Allocation of Assets and Liabilities   Adjustments   Estimated Allocation of Assets and Liabilities as of June 30, 2025 
Cash consideration:               
Cash consideration  $2,000,000   $-   $2,000,000 
Less: cash acquired   (34,983)   -    (34,983)
Cash consideration, net of cash acquired   1,965,017    -    1,965,017 
Noncash consideration:               
Common stock (1)   254,071    250,071    504,142 
Series E preferred stock (2)   255,000    -    255,000 
Accounts receivable in Cycurion owing from SLG (3)   10,814,147    -    10,814,147 
Noncash consideration   11,323,218    250,071    11,573,289 
Total consideration  $13,288,235   $250,071   $13,538,306 
Assets acquired:               
Accounts receivable  $3,066,581   $-   $3,066,581 
Total identified assets acquired   3,066,581    -    3,066,581 
Liabilities assumed:               
Accounts payable   4,317,052    -    4,317,052 
Accrued liabilities   10,650    -    10,650 
Payroll liability   40,642    -    40,642 
Factoring liability   2,176,922    -    2,176,922 
Due to RP   18,000    -    18,000 
Loans payable   625,222    -    625,222 
Liabilities to Cycurion   2,982,908    -    2,982,908 
Total identified liabilities assumed   10,171,396    -    10,171,396 
Net identifiable liabilities assumed   (7,104,815)   -    (7,104,815)
Elimination of inter-company balances   2,982,908    -    2,982,908 
Non-controlling interest   (3,464,218)   -    (3,464,218)
Goodwill   13,945,924    250,071    14,195,995 
Net assets acquired  $13,288,235   $250,071   $13,538,306 

 

(1)Represents the fair value of 1,008,282 common stock issued in the SLG transaction based on the quoted stock price on the date of issuance.
(2)Represents the fair value of the Series E Convertible Preferred Stock as is converted to common stock based on the quoted price common stock on the date of issuance.
(3)Represents the fair value of the accounts receivable in Cycurion owing from SLG.
(4)Fair value of the noncontrolling interest based on NCI’s 49% interest in the net assets acquired.
(5)Goodwill is calculated as Total Consideration paid less the net assets acquired.

 

17

 

 

8. GOODWILL

 

Acquisition of Axxum Technologies, LLC.

 

On November 22, 2017, the Company entered into a share transfer agreement with Axxum and the two prior members of Axxum to purchase 100% of the members’ equity interest in the Company in exchange for $6,500,000 in cash and $500,000 in two subordinated convertible promissory notes for $250,000 each, payable to the two members of Axxum. Accordingly, Axxum became a wholly-owned subsidiary of the Company. The Company assessed the carrying value of Axxum’s assets and liabilities at the date of acquisition and determined that the carrying value of those accounts approximated fair value; the difference between the purchase price paid for the acquisition of Axxum and the net asset value derived from the assets and liabilities of Axxum at the date of acquisition has been recognized as goodwill. Accordingly, the purchase costs of $6,500,000 in cash, $500,000 in promissory notes, and $140,005 in capitalized transaction costs, less $573,150 in adjustment in working capital that is recoverable from sellers resulted in a total purchase cost of $6,566,855; the net asset value of Axxum at the date of acquisition was $1,413,589; accordingly, the Company recognized $5,153,266 in goodwill related to the acquisition of Axxum.

 

Acquisition of Cloudburst Security, LLC.

 

On April 3, 2019, the Company entered into a membership interest purchase agreement with Cloudburst Security, LLC, a Virginia limited liability company, and its two equity holders to purchase 100% of the issued and outstanding units in exchange for $500,000 in cash; $540,000 for a promissory note to one equity holder and $360,000 to the other; and 111,628 and 74,420 shares of the Company’s common stock to the two equity holders, respectively, on a post-split basis. Accordingly, Cloudburst became a wholly-owned subsidiary of the Company. The Company assessed the carrying value of Cloudburst’s assets and liabilities at the date of acquisition and determined that the carrying value of those accounts approximated fair value; the difference between the purchase price paid for the acquisition of Cloudburst and the net asset value derived from the assets and liabilities of Cloudburst at the date of acquisition has been recognized as goodwill. The purchase costs of $500,000 in cash, $900,000 in promissory notes, $300,000 in 186,048 shares of the Company’s common stock, $1,400,000 in contingent earnout, $62,305 in capitalized transaction costs, resulted in a total purchase cost of $3,162,305; the net asset value of Cloudburst at the date of acquisition was $323,267; accordingly, the Company recognized $2,839,038 in goodwill related to the acquisition of Cloudburst. On April 20, 2022, the holders of the (i) $900,000 promissory notes and (ii) 186,048 shares of the Company’s common stock tendered them to the Company for cancellation.

 

Relevant factors to the Company’s assessment of the carrying value of goodwill for both business combinations in accordance to the fair value hierarchy under the category of level 3 are as follows: estimation of the growth rate of future incoming and outgoing cash flows, certain elements that comprise the appropriate weighted average cost of capital, such as the equity of potential market participants for comparability analysis, and the Company’s sensitivity to outside factors that would lead to variation in the aforementioned cash flows and weighted average cost of capital.

 

The Company’s management reviewed the performance of Cloudburst and its manager during the year ended December 31, 2020 and determined that Cloudburst had not met the performance targets set forth at the time of acquisition; as a result, the manager of Cloudburst was dismissed. Management of the Company performed a quantitative analysis of the carrying value of the subsidiary and its related goodwill by preparing a future discounted cash flow analysis, which included variables such as expectations on future cash flows, calculation of the cost of capital, and the probability of capturing certain contracts under the framework of Cloudburst being a federal government approved service provider, and determined that the fair value as of December 31, 2020 was lower than the carrying value that was previously established at the point of acquisition; accordingly, during the year ended December 31, 2020, the Company determined that the contingent earnout should be de-recognized, and written off in its entirety in the amount of $1,400,000 to the Company’s result of operations, and, as a result of the above assessment, the Company recognized an impairment of goodwill in the amount of $1,400,000 that was also recognized to the Company’s results of operations. The Company’s ending goodwill related to the acquisition of Cloudburst after recognizing impairment was $1,439,038.

 

Acquisition of SLG Innovation Inc.

 

The Company initiated discussions to acquire SLG in late 2020, advancing an initial non-refundable deposit of $1.4 million for loans, capitalized transaction costs, and accounts receivable. By December 31, 2024, this deposit had increased to $2 million. On May 13, 2021, the Company entered into an agreement to acquire substantially all of SLG’s assets and certain liabilities, later amended to focus on specific sales contracts. A unidirectional letter of intent (LOI) was executed on April 29, 2023, binding SLG to the transaction while allowing the Company the option to proceed. The LOI contemplated a structure involving the $2 million receivable, $2.1 million in SLG payables to RCR Technology Corporation, and 996,355 shares of the Company’s capital stock.

 

On March 31, 2025, the Company finalized an agreement to acquire 51% equity interest in SLG. The total purchase consideration included the $2 million prepaid deposit, 1,008,282 shares of common stock (par value $0.0001), 51 shares of Series E Preferred Stock (face value $10,000 each, conversion price $1.00) and $10,814,147 of accounts receivable in Cycurion owing from SLG. Additionally, the Company issued 500,000 common shares to assume SLG’s share-based payment obligations.

 

The acquisition was accounted for as a business combination under ASC 805. As of the acquisition date, the fair value of assets acquired totaled $3,066,581, excluding cash of $34,983 that was netted against cash consideration paid. Liabilities assumed amounted to $10,171,396, including accounts payable, accrued liabilities, payroll liabilities, and loans. After recognizing a non-controlling interest of $3,464,218, the net assets acquired were negative $7,104,815. The total consideration transferred exceeded the net assets acquired, resulting in the recognition of goodwill amounting to $14,195,995. This goodwill reflects the strategic value of SLG’s operations, expected synergies, and future growth potential.

 

18

 

 

   June 30, 2025   December 31, 2024 
Table 8: Details of Goodwill
   June 30, 2025   December 31, 2024 
Axxum  $5,153,266   $5,153,266 
Cloudburst   1,439,038    1,439,038 
SLG   14,195,995    - 
Goodwill  $20,788,299   $6,592,304 

 

 

9. BANK LOANS

 

Bank loan-revolving credit line

 

On November 22, 2017, Axxum procured from Main Street Bank a revolving line of credit with a maximum of up to $1,000,000, subject to certain restrictions based on available collateral pledged to the bank in the form of accounts and trade receivables owed by the Company’s customers. This revolving credit line is available for one year, at which point it may be renewed by Axxum. Axxum incurred origination and closing costs for this line of credit in the amount of $10,000, which Axxum has recognized a prepaid expense that will amortize over one year as interest expense. The stated rate of interest of the revolving line of credit is the prime rate plus 100 basis points, which, at the time of the loan, was 4.50%.

 

On April 18, 2019, Axxum, Cloudburst, and the Company collectively renewed the revolving line of credit with a maximum aggregate principal sum of $2,000,000 with Main Street Bank. The stated rate of interest of the revolving line of credit increased to 5.75% at the time of the renewal.

 

On June 29, 2020 and again on June 30, 2021, the Company amended the revolving line of credit with an extension of the maturity date to March 31, 2024. The stated rate of interest of the revolving line of credit decreased to 5.25% at the time of the first amendment and an additional 5% default interest on the second amendment.

 

As of June 30, 2025, the stated rate of interest of the revolving line of credit was 8.50%. The outstanding balance of the line of credit was $3,236,167 and $3,249,067, respectively, as of June 30, 2025 and December 31, 2024.

 

Bank term loan Concurrent with Axxum’s procurement of the above-mentioned revolving credit line, Axxum also procured a term loan from Main Street Bank in the amount of $5,250,000 with an expiration of December 31, 2024. The loan is subject to a monthly repayment of principal in the amount of $109,375. The loan carries a stated adjustable interest rate of the prime rate plus 200 basis points, which, at the time of the loan, was 5.50%. Axxum incurred closing and origination costs totaling $211,729. The imputed interest rate after giving effect for the closing and origination costs was 7.82%.

 

Axxum is subject to the following affirmative loan covenants: (i) on or after December 31, 2017 but prior to June 30, 2018, minimum tangible net worth (net liability) of $2,250,000; on or after June 30, 2018 but prior to June 30, 2019, minimum tangible net worth (net liability) of $1,250,000; on or after June 30, 2019 but prior to December 31, 2019, minimum tangible net worth (net liability) of $950,000; on or after December 31, 2019 but prior to June 30, 2020, minimum tangible net worth (net asset) of $1750,000; on or after June 30, 2020 but prior to December 31, 2020, minimum tangible net worth (net asset) of $2,500,000; on or after December 31, 2020 but prior to June 30, 2021, minimum tangible net worth (net asset) of $3,000,000; on or after June 30, 2021 but prior to December 31, 2021, minimum tangible net worth (net asset) of $3,500,000; on or after December 31, 2021, minimum tangible net worth (net asset) of $5,000,000, (ii) interest coverage ratios must be greater than 1.25-to-1, measured on quarterly basis, using a rolling four-quarter basis, beginning with the fiscal quarter ending December 31, 2017, (iii) the Company and Axxum must achieve minimum consolidated earnings before tax interest, tax, depreciation and amortization of (“EBITDA”) greater than $300,000 per quarter, and (iv) annual capital expenditures must be less than $50,000. Management conferred with the bank regarding the covenants and determined that the Company was in compliance after giving effect to clarification in the definitions and formulas set forth by the bank in regard to the calculation of the above covenants.

 

On April 18, 2019, Axxum, Cloudburst, and the Company collectively amended the Loan and Security Agreement, including the addition of Cloudburst as a borrower. The stated interest rate increased to 6.75% and the loan covenants remained the same.

 

On June 29, 2020, the Company amended and restated the Loan and Security Agreement by extending the maturity date to March 22, 2024 with a monthly repayment of principal in the amount of $62,500 on or after June 22, 2020. The stated interest rate decreased to 6.25%.

 

19

 

 

The loan covenants were replaced as follows: (i) on or after June 30, 2020 but prior to December 31, 2020, minimum tangible net worth (net liability) of $2,750,000; on or after December 31, 2020 but prior to June 30, 2021, minimum tangible net worth (net liability) of $2,250,000; on or after June 30, 2021 but prior to December 31, 2021, minimum tangible net worth (net liability) of $1,750,000; on or after December 31, 2021, but prior to June 30, 2022, minimum tangible net worth (net liability) of $1,250,000; on or after June 30, 2022 but prior to December 31, 2022, minimum tangible net worth (net asset) of $500,000; on or after December 31, 2022, but prior to June 30, 2023, minimum tangible net worth (net asset) of $1,250,000; on or after June 30, 2023 but prior to December 31, 2023, minimum tangible net worth (net asset) of $2,000,000; on or after December 31, 2023, minimum tangible net worth (net asset) of $2,500,000, (ii) interest coverage ratios must be greater than 1.20-to-1, measured on quarterly basis, using a rolling four-quarter basis, beginning with the fiscal quarter ending June 30, 2020 (iii) the Company must achieve minimum consolidated EBITDA greater than $300,000 per quarter, and (iv) annual capital expenditures must be less than $50,000.

 

As of June 30, 2025, the stated rate of interest of the loan was 9.5%. 

 

The Company has categorized balances due within one operating period as current and those payments due after one operating period as long-term. As of June 30, 2025 and December 31, 2024, the Company recorded bank loan-current portion of $620,078, net of debt discount of $0 and $774,095, net of debt discount of $1,097.

 

Pledge agreement

 

Concurrent with Axxum’s procurement of the above-mentioned revolving credit line and loan, Axxum entered into a Pledge Agreement. The following pledges of collateral and credit enhancement were made by Axxum and the Company as the sole member of Axxum: (i) the Company equity ownership in Axxum and (ii) all of Axxum’s assets, such as accounts, instruments, equipment, fixtures, deposit accounts, letter of credit rights, and any other assets. All future debt is subordinated to the bank term loan until the term loan is repaid in full. Personal guarantees have also been made by Emmit McHenry, Kurt McHenry, and Alvin McCoy III, as officers and stockholders of the Company in support of the term loan.

 

On April 18, 2019, Axxum, Cloudburst, and the Company collectively amended the Pledge Agreement, including the addition of Cloudburst as a pledgor. The following pledges of collateral and credit enhancement were made by Axxum, Cloudburst, and the Company: (i) all of the equity of Axxum, Cloudburst and each other subsidiary of the Company then owned or hereafter acquired by the Company and (ii) all rights to which the owner of the pledged equity then or may thereafter become entitled by virtue of owning such pledged equity and being a member of Axxum, Cloudburst, and each other subsidiary of the Company.

 

10. LOANS PAYABLE

 

   June 30, 2025   December 31, 2024 
Table 10: Details of Loans Payable
   June 30, 2025   December 31, 2024 
Loan payable  $405,314   $405,314 
Loan payable - SLG   264,379    - 
Economic injury disaster loan - Cycurion   150,000    150,000 
Economic injury disaster loan - SLG   157,220    - 
Private loan payable   203,623    - 
Funded loans Payable   1,180,536    555,314 
Less: Unamortized debt-issuance costs and discounts   -    - 
Total loans payable   1,180,536    555,314 
Less: Current portion of long-term debt   885,240    408,516 
Long-term debt  $295,296   $146,798 

 

20

 

 

Loan payable

 

On March 20, 2023, the Company entered into a receivable purchase agreement (the “RPA Loan”) for cash received of $339,500, with a specified interest rate of 8.00%, due January 20, 2024. The RPA Loan requires weekly payments of $15,302, until $489,650 is repaid. As of June 30, 2025 and December 31, 2024, the Company recognized a balance owing of $405,314, respectively, and the loan is in default.

 

EIDL Cycurion Loan

 

On July 16, 2020, the Company executed the standard loan documents required for securing loans (the “EIDL Loan - Cycurion”) offered by the U.S. Small Business Administration (the “SBA”) under its Economic Injury Disaster Loan (“EIDL”) assistance program in light of the impact of the COVID-19 pandemic on the Company’s business. The principal amount of the EIDL Cycurion Loan is $150,000, with proceeds to be used for working capital purposes. Interest accrues at the rate of 3.75% per annum and will accrue from the date of the EIDL Cycurion Loan. Installment payments, including principal and interest, are due monthly beginning July 16, 2021 (twelve months from the date of the EIDL Cycurion Loan) in the amount of $731. The balance of principal and interest is payable 30 years from the date of the EIDL Cycurion Loan. The Company recorded note payable as $3,202 of loan payable under current liability as of June 30, 2025 and $295,296 and $146,798 of long-term loan payable, respectively, as of June 30, 2025 and December 31, 2024.

 

EIDL SLG Loan

 

On September 30, 2020, the Company executed the standard loan documents required for securing loans (the “EIDL SLG Loan”) offered by the SBA under its EIDL assistance program in light of the impact of the COVID-19 pandemic on the Company’s business. The principal amount of the EIDL SLG Loan is $150,000, with the proceeds to be used for working capital purposes. Interest accrues at the rate of 3.75% per annum and will accrue from the date of the EIDL SLG Loan. Installment payments, including principal and interest, are due monthly beginning January 1, 2023 in the amount of $731. The balance of principal and interest is payable 30 years from the date of the EIDL SLG Loan (June 30, 2050). As of June 30, 2025, the balance of the EIDL SLG Loan including interest is $157,220.

 

Loan Payable-SLG

 

In 2022 and 2023, the Company entered into non-recourse agreements with a lender to sell future receipts. Under the agreement, the Company was required to make daily payments. The terms were renegotiated to monthly payments in 2023. As of June 30, 2025, the balance on the loan is $264,379 and it is currently in default.

 

Private Loan payable

 

In 2017, the Company entered into a loan agreement with a third party to provide up to $500,000. The funds can be requested on an as-needed basis based on a 10-30% interest rate. As of June 30, 2025, the balance on the loan is $203,623 and is currently in default.

 

11. CONVERTIBLE NOTES

 

Table 11: Rollforward of Convertible Notes
   Principal Value   Unamortized Discount and Issuance Costs   Convertible Notes Carrying Balance   Weighted Average Interest Rate   Maturity
(Calendar Year)
 
Balance as of December 31, 2024   -    -    -           
Issuance   440,217    (53,717)   386,500    18.0%   2026 
Amortization   -    4,476    4,476           
Balance as of March 31, 2025  $440,217   $(49,241)  $390,976    18.0%   2026 
Issuance   2,050,000    (60,000)   1,990,000    15.1%   2026 
Conversion to equity   (2,490,217)   82,465    (2,407,752)   18.0%   2026 
Amortization   -    26,776    26,776           
Balance as of June 30, 2025  $-   $-   $-    0.0%   2026 

 

On June 30, 2025, the Company converted all outstanding convertible notes to Series F preferred stock. See Note 15 – Equity.

 

21

 

 

12. PROMISSORY NOTES

 

Table 12.1: Rollforward of Promissory Notes
   Principal Value   Unamortized Discount and Issuance Costs   Convertible Notes Carrying Balance   Weighted Average Interest Rate 
Balance as of December 31, 2024   2,498,369    (11,380)   2,486,989    16.6%
Issuance   690,558    (77,358)   613,200    13.5%
Repayment   (20,000)   -    (20,000)   35.0%
Amortization   36,667    21,297    57,964      
Balance as of March 31, 2025  $3,205,594   $(67,441)  $3,138,153    15.8%
Conversion to equity   (456,500)   -    (456,500)   24.0%
Repayment   (50,000)   -    (50,000)   24.0%
Amortization   -    37,973    37,973      
Balance as of June 30, 2025  $2,699,094   $(29,468)  $2,669,626    14.3%

 

 

   June 30, 2025   December 31, 2024   Weighted Average Interest Rate   Maturity
(Calendar Year)
 
Table 12.2: Details of Loans Payable
   June 30, 2025   December 31, 2024   Weighted Average Interest Rate   Maturity
(Calendar Year)
 
Note issued in 2017  $250,000   $250,000    4.0%   2020 
Note issued in 2020   300,000    300,000    24.0%   2021 
Note issued in 2021   400,000    400,000    24.0%   2021 - 2022 
Notes issued in 2023   611,111    1,067,611    24.0%   2023 
Notes issued in 2024   517,425    480,758    11.5%   2025 
Notes issued in 2025   620,558    -    12.0%   2025 -2026 
Funded loans payable   2,699,094    2,498,369           
Less: Unamortized debt-issuance costs and discounts   (29,468)   (11,380)          
Total loans payable  $2,669,626   $2,486,989           

 

Subordinated Convertible Promissory notes payable

 

On March 22, 2022, the Company issued subordinated convertible promissory notes with principal value of $526,315 to six investors. While subordinate to bank lender the notes are secured by The Company’s assets. The Company issued to an independent director a $236,842 subordinated convertible note. The Company issued to an otherwise unaffiliated investors of subordinated convertible notes in principal amounts of $52,631 to three investors, $105,263 to a fifth investor and $26,315 to a sixth investor. The notes carry annual interest rate of 8% that commenced upon funding date through the date of repayment.

 

On November 22, 2022, the Company issued to three otherwise unaffiliated investors $2,777,778 promissory notes, 394,011 common shares and 984,557 warrants for $2,500,000 in gross proceeds.

 

The Company entered into the Merger Agreement with Western and Merger Sub, on November 21, 2022, as amended. As a result of the Business Combination, Cycurion raised $3,333,335 of debt capital on November 21, 2022, from nine (9) unaffiliated investors who were issued for convertibles notes, warrants and shares of common stock. The convertible notes had a maturity date of November 21, 2023, and an interest rate of 8%. They were also issued to convert to equity upon completion of the Business Combination between Cycurion and Western.

 

During the first quarter of calendar year 2025, the Company issued preferred stocks and warrants in exchange of the outstanding convertible promissory notes which had an aggregate principal amount of $3,333,335 and accrued interest of $299,259. As a part of this conversion, the Company issued 6,666,667 shares of Series D Convertible Preferred Stock and 7,272,728 Series D warrants to seven (7) unaffiliated noteholders. As a result, the Company recorded gain on settlement of debt of $299,259, which is presented on the consolidated statements of operations and the consolidated statements of cash flows within ‘Loss on debt settlement, net.

 

22

 

 

13. FACTORING LIABILITY

 

On July 12, 2022, the Company entered into agreement with a lender Factor A, whereby the Factor A would loan proceeds against certain accounts receivable up to 90% of the total value of the invoice, which is paid to the Company in the form of a cash advance. A factoring cost of 1.5% is applied for days 1-30 after the loan is funded, and an additional 0.5% fee charge is applied for each additional 10 days period thereafter. The maximum facility is $3.0 million.

 

Accordingly, pursuant to ASC 860-20-55-24, the Company recognized a factoring liability to the lenders until the accounts receivables are collected. As of June 30, 2025, the factoring liability was $2,309,160.

 

14. SERIES A CONVERTIBLE PREFERRED STOCK

 

As of December 31, 2024, the Company had designated 500,000 shares of Series A Convertible Preferred Stock with a par value of $0.001 per share. The Series A had voting rights on an as-if-converted to common stock basis. The holders were entitled to a 10% dividend and convert at any time into shares of common stock at a ratio of 1 to 25.6938 shares of common stock, subject to adjustment.

 

As a part of the Business Combination with Western, the Company issued 106,816 shares of Series A Convertible Preferred Stock, par value $0.0001 per share (“Class A Convertible Preferred Stock”), in connection with the conversion and settlement of previously outstanding securities mentioned above. Refer to Note to 15 for the characteristic of newly issued Series A Convertible Preferred stock.

 

15. EQUITY

 

Preferred Stock

 

The Company has authorized 20,000,000 shares of preferred stock, par value of $0.0001 per share, issuable from time to time in one or more series.

 

The Second Amended and Restated Certificate of Incorporation authorizes the board of directors to establish one or more series of preferred stock. Unless required by law or by any stock exchange, and subject to the terms of the Second Amended and Restated Certificate of Incorporation, the authorized shares of preferred stock will be available for issuance without further action by holders of common stock. The board of directors is able to determine, with respect to any series of preferred stock, designations, powers, preferences and relative, participating, optional or other rights, if any, and the qualifications, limitations, or restrictions thereof, if any.

 

The Company could issue a series of preferred stock that could, depending on the terms of the series, impede or discourage an acquisition attempt or other transaction that some, or a majority, of the stockholders might believe to be in their best interests or in which the stockholders might receive a premium over the market price of the common stock. Additionally, the issuance of preferred stock may adversely affect the rights of stockholders by restricting dividends on the common stock, diluting the voting power of the common stock or subordinating the rights of stockholders to distributions upon a liquidation, dissolution or winding up, or other event. As a result of these or other factors, the issuance of preferred stock could have an adverse impact on the market price of our common stock.

 

Mezzanine Equity

 

As of June 30, 2025 and December 31, 2024, there are zero and 173,879 shares of common stock subject to possible redemption, respectively.

 

Stockholders’ Equity

 

Series A Convertible Preferred Stock

 

The Company has designated 110,000 shares of Series A Convertible Preferred Stock, par value $0.0001 per share.

 

Voting Rights: The holders of our Cycurion’s Series A Stock have voting rights on an as-if-converted-to-Common-Stock basis, and as required by law (including without limitation, the GCL) and as expressly provided in this Certificate of Designation. As long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of the Holders of a majority of the then-outstanding shares of the Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the Preferred Stock or alter or amend this Certificate of Designation, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (c) increase the number of authorized shares of Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

 

Dividend Rights: Holders of shares of Cycurion’s Series A Convertible Preferred Stock shall entitled to receive, dividends on shares of Preferred Stock at the rate of twelve percent (12%) per annum of the per-share Stated Value ($1.45 per share). The dividends shall be paid payable quarterly in arrears in shares of common stock, calculated for each dividend payment on an as-if-converted-to-Common-Stock basis. No other dividends shall be paid on shares of Preferred Stock.

 

Conversion Rights: Shares of Cycurion’s Series A Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series A Convertible Preferred Stock-for-one share of common stock, subject to adjustment.

 

Liquidation Preference: Holders of shares of Cycurion’s Series A Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series A Convertible Preferred Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets of Cycurion shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series A Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

 

23

 

 

Protective Provisions: As long as any shares of Series A Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series A Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series A Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series A Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series A Convertible Preferred Stock, (c) increase the number of authorized shares of Series A Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

 

As part of the acquisition of Western during the first quarter of calendar year 2025, the Company issued to unaffiliated investors a total of zero and 106,816 preferred shares, respectively.

 

As of June 30, 2025 and December 31, 2024, there were 106,816 and zero of Series A Convertible Preferred Stock issued and outstanding, respectively.

 

Series B Convertible Preferred Stock

 

The Company has designated 3,000 shares of Series B Convertible Preferred Stock, par value $0.0001 per share.

 

Voting Rights: Holders of shares of Cycurion’s Series B Convertible Preferred Stock shall not have any voting rights except as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series B Convertible Preferred Stock.

 

Dividend Rights: Holders of shares of Cycurion’s Series B Convertible Preferred Stock shall be entitled to receive, and Cycurion shall pay, dividends on shares of Series B Convertible Preferred Stock (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of common stock when, as, and if such dividends are paid on shares of common stock.

 

Conversion Rights: Shares of Cycurion’s Series B Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series B Convertible Preferred Stock-for-one share of common stock, subject to adjustment.

 

Liquidation Preference: Holders of shares of Cycurion’s Series B Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series B Convertible Preferred Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets of Cycurion shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series B Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

 

Protective Provisions: As long as any shares of Series B Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series B Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series B Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series B Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series B Convertible Preferred Stock, (c) increase the number of authorized shares of Series B Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

 

As part of the acquisition of Western, during the first quarter of calendar year 2025, the Company issued to unaffiliated investors a total of 3,000 preferred shares of series B Convertible Preferred Stock in exchange of existing 3,000 Series B Convertible Preferred Stock.

 

During the six months ended June 30, 2025, a total of 2,999 Series B Convertible Preferred Stock were converted into 5,998,653 shares of common stock.

 

As of June 30, 2025 and December 31, 2024, there were 1 and 3,000 shares of Series B Convertible Preferred Stock issued and outstanding, respectively.

 

24

 

 

Series C Convertible Preferred Stock

 

The Company has designated 5,000 shares of Series C Convertible Preferred Stock, par value $0.0001 per share.

 

Voting Rights: The holders of our Series C Stock have voting rights on an as-if-converted-to-Common-Stock basis, as required by law, and as expressly provided in its Certificate of Designation, as follows. As long as any shares of our Series C Stock are outstanding, we shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of our Series C Stock, (a) alter or change adversely the powers, preferences, or rights given to our Series C Stock or alter or amend its Certificate of Designation, (b) amend our Certificate of Incorporation or other charter documents in any manner that adversely affects any rights of the holders of our Series C Stock, (c) increase the number of authorized shares of our Series C Stock, or (d) enter into any agreement with respect to any of the foregoing.

 

Dividend Rights: We shall pay dividends on our Series C Stock at the rate of 12% per annum of the per-share Stated Value ($82.46 per share). The dividends are payable quarterly in arrears not in cash, but in shares of our common stock, calculated for each dividend payment on an as-if-converted-to-Common-Stock basis. No other dividends are payable on shares of our Series C Stock.

 

Conversion Rights: The shares of our Series C Stock may be converted into shares of our common stock at a ratio of approximately 613 shares of common stock for every one share of our Series C Stock, or an aggregate of 2,972,320 shares of our common stock, assuming full conversion. In connection with conversions, each holder of our Series C Stock is subject to a “beneficial ownership limitation” of 4.99% of the number of shares of our common stock outstanding immediately after giving effect to that conversion, which limitation may be increased by the holder to not more than 9.99% on 61 days’ advanced notice to us.

 

Liquidation Preference: Our Series C Stock has a liquidation preference in an amount equal to its per-share Stated Value ($82.46 per share), plus any accrued and unpaid dividends thereon, for each share of our Series C Stock before we can make any distribution or payment to the holders of our common stock. If our assets are insufficient to pay in full such liquidation preference, then our entire assets are to be distributed to the holders of our Series C Stock, ratably distributed among them in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full.

 

Protective Provisions: As long as any shares of Series C Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series C Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series C Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series C Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series C Convertible Preferred Stock, (c) increase the number of authorized shares of Series C Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

 

As part of the acquisition of Western, during the first quarter of calendar year 2025, the Company issued a total of 4,851 preferred shares of series C Convertible Preferred Stock in exchange of existing 1,356,586 shares of Cycurion common stock and 406,969 Warrants. No conversions occurred during the three months ended June 30, 2025.

 

As of June 30, 2025 and December 31, 2024, there were 4,851 shares of Series C Convertible Preferred Stock issued and outstanding.

 

Series D Convertible Preferred Stock

 

The Company has designated 6,666,700 shares of Series B Convertible Preferred Stock, par value $0.0001 per share.

 

Voting Rights: Holders of shares of Cycurion’s Series D Convertible Preferred Stock shall not have any voting rights except as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series D Convertible Preferred Stock.

 

Dividend Rights: Holders of shares of Cycurion’s Series D Convertible Preferred Stock shall be entitled to receive, and Cycurion shall pay, dividends on shares of Series D Convertible Preferred Stock (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of common stock when, as, and if such dividends are paid on shares of common stock.

 

Conversion Rights: Shares of Cycurion’s Series D Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series B Convertible Preferred Stock-for-one share of common stock, subject to adjustment.

 

25

 

 

Liquidation Preference: Holders of shares of Cycurion’s Series D Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series D Convertible Preferred Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets of Cycurion shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series D Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

 

Protective Provisions: As long as any shares of Series D Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series D Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series D Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series D Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series D Convertible Preferred Stock, (c) increase the number of authorized shares of Series D Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

 

As part of the acquisition of Western, during the first quarter of calendar year 2025, the Company issued to unaffiliated investors a total of 6,666,666 preferred shares of series D Convertible Preferred Stock.

 

During the three months ended as of March 31, 2025, a total of 6,516,666 Series D Convertible Preferred Stock were converted into 6,516,666 shares of common stock. No conversions occurred during the three months ended June 30, 2025.

 

As of June 30, 2025 and December 31, 2024, there were 150,000 and 0 shares of Series D Convertible Preferred Stock issued and outstanding, respectively.

 

Series E Convertible Preferred Stock

 

The Company has designated 100 shares of Series E Convertible Preferred Stock, par value $0.0001 per share.

 

Voting Rights: Holders of shares of Cycurion’s Series E Convertible Preferred Stock shall not have any voting rights except as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series B Convertible Preferred Stock.

 

Dividend Rights: Holders of shares of Cycurion’s Series E Convertible Preferred Stock shall be entitled to receive, and Cycurion shall pay, dividends on shares of Series E Convertible Preferred Stock (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of common stock when, as, and if such dividends are paid on shares of common stock.

 

Conversion Rights: Shares of Cycurion’s Series E Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into shares of common stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series E Convertible Preferred Stock-for-one share of common stock, subject to adjustment.

 

Liquidation Preference: Holders of shares of Cycurion’s Series E Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up of Cycurion, whether voluntary or involuntary, shall be entitled to receive out of the assets, whether capital or surplus, of Cycurion an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share of Series E Convertible Preferred Stock before any distribution or payment shall be made to the holders of common stock, and, if the assets of Cycurion shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of Series E Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

 

Protective Provisions: As long as any shares of Series E Convertible Preferred Stock are outstanding, Cycurion shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series E Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series E Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for Cycurion’s Series E Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series E Convertible Preferred Stock, (c) increase the number of authorized shares of Series E Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

 

As part of the acquisition of SLG Innovation, during the first quarter of calendar year 2025, the Company issued to the majority shareholder a total of 51 preferred shares of series E Convertible Preferred Stock as consideration for the transaction. No issuances occurred during the three months ended June 30, 2025.

 

26

 

 

Series F Convertible Preferred Stock

 

The Company has designated 10,000 shares of our Series F Convertible Preferred Stock, par value $0.0001 per share.

 

Voting Rights: Holders of shares of our Series F Convertible Preferred Stock shall have voting rights on an as-if-converted-to-Common-Stock basis and as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and Limitations for our Series F Convertible Preferred Stock.

 

Dividend Rights: Holders of shares of our Series F Convertible Preferred Stock shall be entitled to receive, and we shall pay, dividends on shares of our Series F Convertible Preferred Stock at the rate of twelve percent (12%) per annum of the $0.0001 per-share Stated Value of the Series F Convertible Preferred Stock. The dividends shall be paid payable quarterly in arrears in shares of Common Stock, calculated for each dividend payment on an as-if-converted-to-Common-Stock basis.

 

Conversion Rights: Shares of our Series F Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into shares of Common Stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series F Convertible Preferred Stock-for-1,000 shares of Common Stock, subject to adjustment.

 

Liquidation Preference: Holders of shares of our Series F Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up, whether voluntary or involuntary , shall be entitled to receive out of the assets, whether capital or surplus, an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share Series F Convertible Preferred Stock before any distribution or payment shall be made to the holders of Common Stock, and, if the assets shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of our Series F Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

 

Protective Provisions: As long as any shares of Series F Convertible Preferred Stock are outstanding, we shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series F Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series F Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for our Series F Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series F Convertible Preferred Stock, (c) increase the number of authorized shares of Series F Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

 

Series G Convertible Preferred Stock

 

The Company has designated 10,000 shares of our Series G Convertible Preferred Stock, par value $0.0001 per share.

 

Voting Rights: Holders of shares of our Series F Convertible Preferred Stock shall have voting rights on an as-if-converted-to-Common-Stock basis and as required by law (including without limitation, the DGCL) and as expressly provided in the Certificate of Designation of Preferences, Rights and Limitations for our Series G Convertible Preferred Stock.

 

Dividend Rights: Holders of shares of our Series G Convertible Preferred Stock shall be entitled to receive, and we shall pay, dividends on shares of our Series G Convertible Preferred Stock at the rate of twelve percent (12%) per annum of the $0.0001 per-share Stated Value of the Series G Convertible Preferred Stock. The dividends shall be paid payable quarterly in arrears in shares of Common Stock, calculated for each dividend payment on an as-if-converted-to-Common-Stock basis.

 

Conversion Rights: Shares of our Series G Convertible Preferred Stock shall be convertible, at any time and from time to time at the option of the holder thereof, into shares of Common Stock (subject to certain 4.99% or 9.99% blocker limitations) at the conversion ratio of one share of Series F Convertible Preferred Stock-for-1,000 shares of Common Stock, subject to adjustment.

 

Liquidation Preference: Holders of shares of our Series G Convertible Preferred Stock, upon any liquidation, dissolution, or winding-up, whether voluntary or involuntary , shall be entitled to receive out of the assets, whether capital or surplus, an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon, for each share Series G Convertible Preferred Stock before any distribution or payment shall be made to the holders of Common Stock, and, if the assets shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders of shares of our Series G Convertible Preferred Stock shall be ratably distributed among them in accordance with the respective amounts that would have been payable on such shares if all amounts payable thereon had been paid in full.

 

Protective Provisions: As long as any shares of Series G Convertible Preferred Stock are outstanding, we shall not, without the affirmative vote of the holders of a majority of the then-outstanding shares of Series G Convertible Preferred Stock, (a) alter or change adversely the powers, preferences, or rights given to the holders of Series G Convertible Preferred Stock or alter or amend the Certificate of Designation of Preferences, Rights and Limitations for our Series F Convertible Preferred Stock, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of shares of Series G Convertible Preferred Stock, (c) increase the number of authorized shares of Series F Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.

 

Common Stock

 

The Company has authorized 100,000,000 shares of common stock, par value of $0.0001 per share. Each share of common stock entitles the holder to one vote, in person or proxy, on any matter on which an action of the stockholders of the Company is sought.

 

12,515,319 shares for conversion of Series B Convertible Preferred Stock and D Convertible Preferred Stock
   
7,044,917 shares for exercise of other warrant, Warrant A, B and D for $3,309,921
   
750,000 shares valued at $9,000,000 for business acquisition costs
   
78,803 shares valued at $945,628 for a settlement of debt of $788,803, as a result, the Company recorded loss on settlement of debt of $157,606, which is presented on the consolidated statements of operations and the consolidated statements of cashflows within in 'loss of debt settlement, net
   
3,926,072 shares valued at $3,834,777 for an employment agreement
   
1,008,282 shares valued at $764,020 for an acquisition of SLG
   
78,983 shares for a release of common stock subject to redemption

 

As of June 30, 2025 and December 31, 2024, there were 40,353,983 and 10,592,607 shares of common stock issued and outstanding, respectively. The 40,353,983 shares of common stock include 624,864 shares of common stock to be issued to SLG and under certain equity plans.

 

Warrants

 

Table 15: Rollforward of all Warrants

 

   Number of Warrants   Weighted Average Exercise Price   Weighted Average Life (years) 
Outstanding warrants, December 31, 2024   9,450,840   $0.69    3.0 
Granted   26,099,773    5.50    4.7 
Replacement of old warrants   (9,450,840)   0.69    2.9 
Exercised   (7,044,917)   0.48    4.3 
Outstanding warrants, March 31, 2024   19,054,856    7.36    4.7 
Issued - Prefunded (equity line)   4,500,000    -    1.0 
Exercised - Prefunded (equity line)   (2,500,000)   -    1.0 
Exercised   (709,000)   0.50    5.0 
Outstanding warrants, June 30, 2025   20,345,856    7.62    4.8 
                
Exercisable warrants, June 30, 2025   20,345,856   $7.62    4.8 

 

The Company has accounted for the issuance of common stock and warrants issued for cash proceeds in the private placements as equity instruments. Management believes that the warrants are indexed to and are settled in the Company’s own common stock; therefore, they should be accounted for as permanent equity.

 

Public Warrants

 

As of June 30, 2025 and December 31, 2024, there were 11,500,000 public warrants (“Public Warrants”) outstanding. The Company accounts for the Public Warrants as equity instruments. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the initial public offering. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If neither that exemption nor another exemption is available, holders will not be able to exercise their warrants on a cashless basis.

 

27

 

 

The Public Warrants will expire on February 14, 2030, five years after the completion of the Business Combination with Cycurion or earlier upon redemption or liquidation.

 

Once the Public Warrants become exercisable, the Company may redeem the Public Warrants:

 

in whole and not in part

 

at a price of $0.01 per Public Warrant;

 

upon not less than 30 days’ prior written notice of redemption;

 

if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period commencing at any time after the Public Warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and

 

if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the Public Warrants.

 

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

 

The exercise price and number of shares of common stock issuable on exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger, or consolidation. However, the warrants will not be adjusted for issuances of shares of common stock at a price below their respective exercise prices. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire and become worthless.

 

In addition, if (a) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by them prior to such issuance), (b) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (c) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Public Warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) the price at which the Company issues the additional shares of common stock or equity-linked securities.

 

Private Placement Warrants

 

As of June 30, 2025 and December 31, 2024, there were 376,000 private placement warrants (“Private Placement Warrants”) outstanding. The Company accounts for the Private Placement Warrants as equity instruments. The Private Placement Warrants sold in the private placement are identical to the Public Warrants underlying the Units sold in the IPO, except that such warrants, and the shares of common stock issuable upon the exercise of such warrants, will not be transferable, assignable, or salable until after February 14, 2025, the date of completion of a Business Combination, subject to certain limited exceptions.

 

Series A Warrants

 

On November 17, 2017, the Company had issued 1,333,336 Series A warrants at exercise price of $0.45 with expiry on November 22, 2025. As part of the acquisition of Western, during the first quarter of calendar year 2025, the Company issued to unaffiliated investors a total of 680,875 series A warrants in exchange of existing 1,333,336 series A warrants having expiry on February 19, 2029 and exercise price of $0.319707

 

Series B Warrants

 

On August 1, 2023, the Company had issued 4,000,000 Series B warrants with an exercise price of $0.50. with expiry on August 1, 2028.

 

28

 

 

On April 12, 2024, the Company issued 2,000,000 Series B warrants with an exercise price of $0.50. The warrants will expire on April 12, 2029.

 

As part of the acquisition of Western, during the first quarter of calendar year 2025, the Company issued to unaffiliated investors a total of 6,000,000 series B warrants in exchange of existing 6,000,000 series B warrants having expiry on February 19, 2030 and exercise price of $0.50.

 

Series D Warrants

 

On March 22, 2022, the Company had issued 196,911 warrants with subordinated convertible promissory note at exercise price of $1.41 with the expiry on September 22, 2027. 

 

On November 22, 2022, the Company had issued 984,557 warrants with subordinated convertible promissory note at exercise price of $1.41with the expiry on April 21, 2028.

 

As part of the acquisition of Western, during the first quarter of calendar year 2025, the Company issued to unaffiliated investors a total of 7,272,728 series D warrants in exchange of existing 1,181,468 series D warrants having expiry on February 19, 2029 and exercise price of $0.50

 

Other Warrants

 

On March 8, 2022, the Company had issued 529,067 warrants to the originators of $700,000 of investor notes at exercise price of $0.92 with the expiry on March 8, 2026.

 

As part of the acquisition of Western, during the first quarter of calendar year 2025, the Company issued to unaffiliated investors a total of 270,171 warrants in exchange of existing 529,067 warrants having expiry on February 19, 2029 and exercise price of $0.319707

 

16. CONCENTRATIONS, RISKS AND UNCERTAINTIES

 

Credit risk

 

The Company’s primary bank deposits are located in the United States. Those deposits are provided protection under FDIC insurance up to maximum of $250,000. Any deposits in excess of the aforementioned maximum are at risk of loss if those banks become insolvent.

 

The Company is subject to risk borne from credit extended to customers.

 

Interest risk

 

The Company is subject to interest rate risk when its loans become due and require refinancing or if the prime rate adjusts, as the Company’s loans are based on adjustable interest rates.

 

Inflation risk

 

Management monitors changes in prices levels. Historically, inflation has not materially impacted the Company’s financial statements; however, significant increases in the cost of labor that cannot be passed on to the Company’s customers could adversely impact the Company’s results of operations.

 

Concentration risks

 

Table 16.1: Revenue Concentration by Customer - Greater than 10% of Revenue

 

   For the Three Months Ended   For the Six Months Ended 
   June 30, 2025   June 30, 2024   June 30, 2025   June 30, 2024 
Customer  Amount   %   Amount   %   Amount   %   Amount   % 
A  $1,138,481    29.3%  $906,889    18.1%  $2,251,053    29.0%  $1,793,879    19.4%
B   594,460    15.3%   567,472    11.3%   1,158,080    14.9%   1,169,039    12.6%
C   374,780    9.6%   815,756    16.3%   861,958    11.1%   1,592,437    17.2%
D   343,460    8.8%   649,819    13.0%   732,740    9.4%   1,189,496    12.9%

 

29

 

 

Table 17.2: Accounts Receivable Concentration by Customer - Greater than 10% of Accounts Receivable

 

   June 30, 2025 
Customer  Amount   % 
1  $

1,284,470

    

31
%
2   

911,832

    22%
3   

585,852

    14%

 

Prior to the acquisition of SLG on March 31, 2025, the company had combined all SLG customers as one customer for purposes of customer concentration disclosures due to the nature of the relationship. Once the acquisition was complete, the company has re-evaluated this disclosure to break out all SLG customers individually, therefore the amounts reported above are not comparable to Q1 2025 amounts previously reported. As of December 31, 2024, no individual customer accounts receivable balances were 10% or greater than the total account receivable balance.

 

17. FAIR VALUE DISCLOSURES

 

The Company estimates the fair value of its debt by discounting the future cash flows of each instrument using estimated market rates of debt instruments with similar maturities and credit profiles. These inputs are classified as Level 3 within the fair value hierarchy. As of June 30, 2025 and December 31, 2024, the carrying value reported in the consolidated balance sheet for the Company’s notes payable approximated its fair value.

 

There were no assets or liabilities recorded at fair value on a recurring basis as of June 30, 2025. As of December 31, 2024 the Company had recorded liabilities at fair value on a recurring basis for subordinated convertible promissory notes and series A convertible preferred stock and equity warrants at fair value on a recurring basis. The subordinated convertible promissory notes carry an interest rate that is indicative of the Company’s overall borrowing cost and the length of time until maturity is not expected to significantly impact their value. The convertible preferred stock, which is akin to debt, has been discounted to its presented carrying value in accordance with the debt discounts and redemption premiums recognized.

 

Assets and liabilities that are measured at fair value on a non-recurring basis include intangible assets and goodwill. These items are recognized at fair value when they are considered to be impaired.

 

There were no fair value adjustments for assets and liabilities measured on a non-recurring basis. The Company discloses fair value information about financial instruments for which it is practicable to estimate that value.

 

Table 12.1: Fair Value Hierarchy - 2024

 

   Level 1   Level 2   Level 3   Total 
   As of December 31, 2024 
   Level 1   Level 2   Level 3   Total 
Liabilities:                
Subordinated convertible promissory notes  $-   $-   $5,490,324   $5,490,324 
Series A convertible preferred stock   -    -    1,294,117    1,294,117 
Total liabilities  $-   $-   $6,784,441   $6,784,441 
Equity:                    
Warrants  $-   $-   $2,687,074   $2,687,074 
Total equity  $-   $-   $2,687,074   $2,687,074 

 

 

18. RELATED PARTY TRANSACTIONS

 

Promissory Note – Related Party

 

On September 20, 2024, the Company entered into a promissory note with the Sponsor for $230,000, pursuant to which the Company can borrow up to an aggregate principal amount of $230,000. The Promissory Note, with an interest rate of 10% per annum is payable upon the sooner of the consummation of the Business Combination with Cycurion. As of June 30, 2025, the Company had borrowed the full $230,000 and nothing was available for withdrawal. The Company deemed the interest on the loan to be immaterial and as such did not record any interest relating to the note as of June 30, 2025.

 

30

 

 

Personal guarantees were entered by Emmit McHenry, Kurt McHenry, and Alvin McCoy III, as officers and stockholders of the Company in support of the Main Street Bank loan.

 

Axxum purchased an AT&T contract relationship from Archura, LLC, a company owned by Emmit McHenry and Kurt McHenry at the end of 2018. The contract relationship includes five purchase orders to deliver networking services to AT&T and its clients. The total sales of these five purchase orders were $83,790 and $119,279, as of June 30, 2025 and December 31, 2024, respectively. 

 

Loans payable

 

Table 18: Details of Loans Payable - Related Party

 

   June 30, 2025   December 31, 2024   Weighted Average Interest Rate   Maturity
(Calendar Year)
 
Loans to two directors issued in 2023  $130,900   $130,900    24.0%   2023 
Loan to a director issued in 2024   20,250    20,250    24.0%   2025 
Funded loans payable - related party principal   151,150    151,150           
Less: Unamortized debt-issuance costs and discounts   (778)   (3,062)          
Loans payable - related party - current  $150,372   $148,088           

 

During the six months ended June 30, 2025 and 2024, the Company record amortization of debt discount of $2,285 and $0, respectively.

 

19. EARNINGS PER SHARE

 

Table 19.1: Details of Basic and Dilutive (Loss)/Earnings Per Share

 

   June 30, 2025   June 30, 2024   June 30, 2025   June 30, 2024 
   For the Three Months Ended   For the Six Months Ended 
   June 30, 2025   June 30, 2024   June 30, 2025   June 30, 2024 
Basic net (loss)/income per share:                    
Numerator                    
Net (loss)/income including non-controlling interests  $(5,290,418)  $306,094   $(15,538,900)  $(6,381)
Less: Net (loss)/income attributable to non-controlling interest   (101,659)   -    (101,659)   - 
Net (loss)/income attributable to common stockholders - basic   (5,188,759)   306,094    (15,437,241)   (6,381)
Denominator                    
Weighted average shares outstanding - basic   34,791,716    14,968,215    26,707,978    14,968,215 
Basic net (loss)/income per share attributable to common stockholders  $(0.15)  $0.02   $(0.58)  $(0.00)
Diluted net (loss)/income per share:                    
Numerator                    
Net (loss)/income attributable to common stockholders - basic  $(5,188,759)  $306,094   $(15,437,241)  $(6,381)
Add back interest for subordinated convertible promissory note   2,500    2,500    38,333    5,000 
Net (loss)/income attributable to common stockholders - diluted  $(5,186,259)  $308,594   $(15,398,908)  $(1,381)
Denominator                    
Weighted average shares outstanding - basic   34,791,716    14,968,215    26,707,978    14,968,215 
Weighted-average effect on of potentially dilutive securities:                    
Conversion of subordinated convertible promissory note   100,000    100,000    100,000    1,736,533 
Conversion of series A convertible preferred stock   -    2,106,075    -    - 
Conversion of series B convertible preferred stock   -    5,758,242    -    - 
Exercise of investor and placement agent warrants   -    9,450,840    -    - 
Weighted average shares outstanding - diluted   34,891,716    32,383,372    26,807,978    16,704,748 
Dilutive net (loss)/income per share attributable to common stockholders  $(0.15)  $0.01   $(0.57)  $(0.00)

 

Table 19.2: Details of Potentially Dilutive Effect of Securities Excluded from Dilutive EPS due to Anti-Dilutive Effect

 

   June 30, 2025   June 30, 2024   June 30, 2025   June 30, 2024 
   For the Three Months Ended   For the Six Months Ended 
   June 30, 2025   June 30, 2024   June 30, 2025   June 30, 2024 
Conversion of series A convertible preferred stock   4,533,786    -    3,431,650    2,106,075 
Conversion of series B convertible preferred stock   1,347    -    1,698,031    4,879,121 
Conversion of series C convertible preferred stock   36,045    -    36,045    - 
Conversion of series D convertible preferred stock   150,000    -    457,934    - 
Conversion of series E convertible preferred stock   51    -    26    - 
Exercise of investor and placement agent warrants   18,397,647    -    14,749,573    9,450,840 

 

31

 

 

20. COMMITMENTS AND CONTINGENCIES

 

Registration Rights

 

The holders of Founder Shares, Private Placement Units, and units that may be issued upon conversion of Working Capital Loans, if any, are entitled to registration rights pursuant to a registration rights agreement that was signed on the date of the IPO. These holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up period for the securities to be registered. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Business Combination Marketing Agreement

 

The Company entered into a business combination marketing agreement on January 11, 2022 (the “Business Combination Marketing Agreement”) with Alliance Global Partners/A.G.P. (“A.G.P.”) whereby A.G.P. is to act as an advisor in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholders’ approval for a Business Combination, and assist the Company with its press releases and public filings in connection with a Business Combination. The Company was to pay A.G.P. a fee for such marketing services upon the consummation of a Business Combination in an amount equal to 4.5% of the gross proceeds of the IPO, or $5,175,000 in the aggregate (exclusive of any applicable finders’ fees that might become payable). The Business Combination Marketing Agreement will be terminated upon entry into the Advisory Agreement (described below).

 

Advisory Agreement with A.G.P.

 

A.G.P. was a financial advisor to both Western in connection with the Business Combination transaction. Upon the completion of the Business Combination, A.G.P.: (i) received a cash fee of $500,000 shares of common stock and warrants to purchase 500,000 shares of common stock at an exercise price of $5.00 per share. Pursuant to the advisory agreement (the “Advisory Agreement”), Western shall pay A.G.P. a total transaction fee equal to $2,500,000 (the “Transaction Fee”) upon the closing of the Business Combination. The Transaction Fee will be payable in the form of preferred shares of Cycurion that are convertible into 500,000 shares of common stock (such preferred shares or the common stock into which they convert, the “Transaction Fee Shares”), for a price per share of common stock equal to $5.00. A portion of the Transaction Fee Shares shall be subject to forfeiture and return to the Company for cancellation once A.G.P. converts and sells Transaction Fee Shares generating sales proceeds (excluding commissions) of $2,500,000.

 

The Transaction Fee Shares shall be subject to a lock-up ending on the earlier of (i) the date on which 75% of the outstanding Series B Convertible Preferred Stock is converted into shares of the Combined Company’s common stock and (ii) three months from February 14, 2025, which was the closing date of the de-SPAC (the “Lock-Up Termination Date”). After the Lock-Up Termination Date, A.G.P. may convert the Transaction Fee Shares and sell them subject to a leak-out provision that limits A.G.P.’s sales of Transaction Fee Shares on any given date to 10% of the cumulative trading volume of the common stock for such date (including pre-market, market and post-market trading) as reported by Bloomberg, LP. This restriction shall remain in effect beginning on the Lock-Up Termination Date and ending on the date on which 100% of the Series B Convertible Preferred Stock outstanding as of the closing is converted into shares of our common stock.

 

The parties amended the Advisory Agreement (the “Amended Advisory Agreement”), pursuant to which Western shall pay A.G.P. the Transaction Fee in the form of preferred shares of Cycurion that are convertible into 5,000,000 shares of common stock (such preferred shares or the common stock into which they convert, the “Amended Transaction Fee Shares”), for a price per share of common stock of $0.50. A portion of the Amended Transaction Fee Shares shall be subject to forfeiture and return to the Company for cancellation once A.G.P. converts and sells Transaction Fee Shares generating sales proceeds (excluding commissions) of $2,500,000.

 

The Amended Transaction Fee Shares shall be subject to a lock-up ending on the earlier of (i) the date on which 75% of the outstanding Series B Convertible Preferred Stock is converted into shares of the Combined Company’s common stock and (ii) six months from the Lock-Up Termination Date. After the Lock-Up Termination Date, A.G.P. may convert the Amended Transaction Fee Shares and sell them subject to a leak-out provision that limits A.G.P.’s sales of Amended Transaction Fee Shares on any given date to 10% of the cumulative trading volume of the common stock for such date (including pre-market, market and post-market trading) as reported by Bloomberg, LP. This restriction shall remain in effect beginning on the Lock-Up Termination Date and ending on the date on which 100% of the Series B Convertible Preferred Stock outstanding as of the closing is converted into shares of our common stock.

 

Upon the execution of the Advisory Agreement, the Business Combination Marketing Agreement, dated January 11, 2022, between Western and A.G.P. in which Western and Cycurion Sub caused the combined company to issue to A.G.P. 250,000 shares of common stock of the combined company in full satisfaction of the fees, was terminated, and such shares of common stock extinguished in their entirety.

 

Agreements with Seward & Kissel LLP

 

On November 27, 2024, we entered into a revised engagement letter (the “Revised Engagement Letter”) with Seward & Kissel LLP (“Seward & Kissel”), pursuant to which Western and Cycurion agreed to pay approximately $1.3 million of its outstanding legal fees and expenses (“Legal Fees”) in shares of common stock in connection with the Business Combination. Following the closing of the Business Combination on February 14, 2025 and in connection with the Revised Engagement Letter, we issued to Seward & Kissel 250,000 shares of common stock and a pre-funded warrant that is exercisable for approximately $1.3 million in shares of common stock (the “Seward & Kissel Pre-Funded Warrant”); provided that once the net proceeds from the sale of the shares equals the Legal Fees, the remaining shares of common stock, including such common stock exercisable under the Seward & Kissel Pre-Funded Warrant, shall be returned to the Cycurion. We plan to enter into an exchange agreement with Seward & Kissel to exchange the Seward & Kissel Pre-Funded Warrant for a convertible promissory note that is convertible into such number of shares equal to the Legal Fees.

 

On February 14, 2025, Cycurion entered into pre-funded warrant with Seward & Kissel Pre-Funded Warrant that is exercisable for approximately $1.3 million in shares of Common Stock, or up to 2,500,000 shares of Common Stock; provided that once the net proceeds from the sale of the shares equals the $1.3 million in Legal, the remaining shares of Common Stock, including such Common Stock exercisable under the Seward & Kissel Pre-Funded Warrant, shall be returned to Cycurion.

 

The Seward & Kissel Pre-Funded Warrant provides that the holder may not exercise any portion of the Seward & Kissel Pre-Funded Warrant to the extent that immediately prior to or after giving effect to such exercise the holder would own more than 4.99% upon 61 days’ prior notice. The exercise price for each share of Common Stock underlying the Seward & Kissel Pre-Funded Warrant is $0.0001. The Seward & Kissel Pre-Funded Warrant is immediately exercisable upon issuance and may be exercised at any time until the Seward & Kissel Pre-Funded Warrant is exercised in full.

 

Seward & Kissel LLP may not exercise any portion of the warrants or Seward & Kissel Pre-Funded Warrant, as applicable, to the extent that the holder would own more than 4.99% of our outstanding Common Stock immediately after exercise, as such percentage ownership is determined in accordance with the terms of the Seward & Kissel Pre-Funded Warrant.

 

In lieu of making the cash payment otherwise contemplated to be made to us upon exercise of the Seward & Kissel Pre-Funded Warrant in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of our Common Stock determined according to a formula set forth in the Seward & Kissel Pre-Funded Warrant.

 

Agreement with Baker & Hostetler LLP

 

In 2023, Western agreed to pay approximately $788,030 of its obligations to its counsel, Baker Hostetler LLP, in shares of common stock following the Business Combination, which will be issued at a price per share equal to $10.00, or 78,803 shares.

 

32

 

 

Equity Line of Credit

 

Equity Purchase Agreement

 

On April 7, 2025 (the “Execution Date”), we entered into the Equity Purchase Agreement with the Investor. Under the Equity Purchase Agreement, we have the right, but not the obligation, to direct the Investor to purchase up to $60 million (the “Maximum Commitment Amount”) in shares of our common stock upon satisfaction of certain terms and conditions contained in the Equity Purchase Agreement, including, without limitation, an effective registration statement filed with the SEC registering the resale of the shares of Put Stock (defined below) and the shares of Commitment Stock (defined below) and additional shares to be sold to the Investor from time to time under the Equity Purchase Agreement. The term of the Equity Purchase Agreement began on the Execution Date and ends on the earlier of (i) the date on which the Investor shall have purchased shares of common stock issued, or that we shall be entitled to issue, per any applicable Put Notice in accordance with the terms and conditions of the Equity Purchase Agreement (the “Put Stock”) equal to the Maximum Commitment Amount, (ii) the date that is twelve (12) months from the date the registration statement is declared effective, (iii) written notice of termination by us to the Investor (which shall not occur at any time that the Investor holds any of the shares of Put Stock), or (iv) written notice of termination by the Investor to us pursuant to (the “Commitment Period”).

 

During the Commitment Period, we may direct the Investor to purchase shares of Put Stock by delivering a notice (a “Put Notice”) to the Investor. We shall, in our sole discretion, select the number of shares of Put Stock requested in each Put Notice. However, such amount may not exceed the Maximum Put Amount (as defined in the Equity Purchase Agreement). The purchase price to be paid by the Investor for the shares of Put Stock will be ninety percent (90%) of the lowest trade of the common stock on the Principal Market during the Valuation Period (as defined in the Equity Purchase Agreement).

 

In consideration for the Investor’s execution and delivery of, and performance under the Equity Purchase Agreement, on the Execution Date, we, in our discretion, either were to (i) pay to the Investor in cash $1,800,000 (“Commitment Cash”) or (ii) issue the Pre-Funded Warrant to the Investor in a form acceptable to the Investor in its sole discretion and having an exercise price per share of $0.0001, for the Investor’s purchase of shares of common stock (the “Commitment Stock”) having a value of $1,800,000 based on closing price of the common stock on April 6, 2025. We chose to issue the Pre-Funded Warrant. All of the shares of Commitment Stock were fully earned as of the Execution Date, and the issuance of the shares of Commitment Stock is not contingent upon any other event or condition, including, without limitation, the effectiveness of the Initial Registration Statement (defined below) or our submission of a Put Notice to the Investor and irrespective of any termination of the Equity Purchase Agreement.

 

In accordance with the Equity Purchase Agreement, a registration statement on Form S-1 (the “Initial Registration Statement”) covering only the resale of the shares of Put Stock and Commitment Stock was filed with the SEC on May 7, 2025.

 

Pre-Funded Warrant

 

The Pre-Funded Warrant certifies that, for value received, the Investor is entitled to be issued up to 4,500,000 shares of common stock as its Commitment Fee and has an initial exercise price of $0.0001 per share. The Pre-Funded Warrant may not be exercised if the aggregate number of shares of the common stock beneficially owned by the holder would exceed 4.99% immediately after exercise thereof, which ownership cap may be increased by the holder up to 9.99% upon 61 days’ prior notice (the “Beneficial Ownership Limitation”). During the three months and six months ended June 30, 2025, 2,500,000 of these shares have been exercised, with a remaining unexercised 2,000,000 shares.

 

Registration Rights Agreement

 

On April 7, 2025 (the “RRA Execution Date”), in connection with the Equity Purchase Agreement, we entered into a registration rights agreement with the Investor (the “Registration Rights Agreement”), pursuant to which we shall, by May 7, 2025, file with the SEC the Initial Registration Statement covering the maximum number of (i) shares of Commitment Stock, (ii) shares of Put Stock, which have been, or which may, from time to time be issued, including without limitation all of the shares of common stock which have been issued or will be issued to the Investor under the Equity Purchase Agreement (without regard to any limitation or restriction on purchases), and (iii) any and all shares of capital stock issued or issuable with respect to the Put Stock, Commitment Stock, and the Equity Purchase Agreement as a result of any stock split, combination, stock dividend, recapitalization, exchange, or similar event, or otherwise, without regard to any limitation on purchases under the Equity Purchase Agreement (the “Registrable Securities”), as shall be permitted to be included thereon in accordance with applicable SEC rules, regulations, and interpretations so as to permit the resale of the Registrable Securities by the Investor, including, but not limited to, under Rule 415 at then-prevailing market prices (and not fixed prices). The Initial Registration Statement shall register only Registrable Securities. We shall use our commercial best efforts to have the Initial Registration Statement and any amendment thereto declared effective by the SEC at the earliest possible date, but in no event later than July 7, 2025.

 

Non-Redemption Agreement

 

On August 6, 2024, the Company, Western Acquisition Ventures Sponsor, LLC (the “Sponsor”) and RiverNorth SPAC Arbitrage Fund, LP (the “RiverNorth”) entered into a non-redemption agreement (the “Non-Redemption Agreement”) whereby the Sponsor plans to transfer to the Investor 5,000 shares each month over the next three months for agreeing not to redeem the 99,800 that it currently holds prior to the business combination.

 

33

 

 

On October 9, 2024, the Company, the Sponsor and RiverNorth entered into extended non-redemption agreement whereby the Sponsor plans to transfer to RiverNorth 5,000 shares each month over the next three months for agreeing not to redeem the 99,800 that it currently holds prior to the business combination.

 

Employment Agreements

 

On December 27, 2023, we entered into an employment agreement with James P. McCormick whereby the Company agreed to pay a total of $125,000 of total compensation annually, including $40,000 in cash and $85,000 in stock payment. On October 30, 2024, we entered into an amendment to the employment agreement with James P. McCormick whereby the Company agreed to pay total compensation of $200,000, including $40,000 in cash at the closing of the Business Combination and the remaining $160,000 in cash from the proceeds that the Company receives from any capital raising transaction following the closing of the Business Combination, including the proceeds from an equity line of credit to be entered into by and among the Company, Cycurion and the investors named therein; provided that the Company shall only be obligated to apply up to 15% of the proceeds from each capital raise until Mr. McCormick’s compensation of $200,000 has been paid in full.

 

On December 1, 2024, Cycurion and L. Kevin Kelly, Chief Executive Officer, entered into an employment agreement on a two-year term, commencing on December 1, 2024 and ending on December 1, 2026. During the employment period, Mr. Kelly will receive an annual base salary of $325,000, and equity compensation of $500,000 of Company common stock in the first year of the employment agreement, payable quarterly. Mr. Kelly is eligible for a performance bonus based on the Company’s results. The targeted performance bonus is $325,000 for year-one, and the performance bonus will increase for subsequent years based on future financial and non-financial results

 

On January 1, 2025, Cycurion and Alvin McCoy, III, Chief Financial Officer, entered into an employment agreement on a two-year term, commencing on January 1, 2025 and ending on December 31, 2026. During the employment period, Mr. McCoy, III will receive an annual base salary of $325,000 and equity compensation of $500,000 of Company stock in the first year of the employment agreement, payable quarterly. Mr. McCoy, III is eligible for a performance bonus based on the Company’s performance. The targeted performance bonus is $325,000 for year-one, and the performance bonus will increase for subsequent years based on future financial and non-financial results.

 

Retention Packages

 

On June 16, 2025, the Board of Directors approved a retention package for L. Kevin Kelly, Chief Executive Officer, and Alvin McCoy III, Chief Financial Officer, and issued each officer 3,000,000 shares of Common Stock under the Company’s 2025 Equity Incentive Plan.

 

Inflation Reduction Act of 2022 (the “IR Act”)

 

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax.

 

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a business combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a business combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the business combination, extension or otherwise, (ii) the structure of a business combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a business combination (or otherwise issued not in connection with a business combination but issued within the same taxable year of a business combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a business combination and in the Company’s ability to complete a business combination.

 

As of June 30, 2025 and December 31, 2024, the Company’s stockholders have redeemed a total of 11,421,017 and 11,326,121 shares of common stock resulting in $1,167,174 and $1,157,161 of excise tax liability, calculated as 1% of the value of the shares redeemed, respectively

 

21. SUBSEQUENT EVENTS

 

The Company evaluates subsequent events that have occurred after the balance sheet date but before the financial statements are issued which is up to and through August 13, 2025. There are two types of subsequent events: (i) recognized, or those that provide additional evidence with respect to conditions that existed at the date of the balance sheet, including the estimates inherent in the process of preparing consolidated financial statements, and (ii) non-recognized, or those that provide evidence with respect to conditions that did not exist at the date of the balance sheet but arose subsequent to that date.

 

During the month of July 2025, all remaining 2,000,000 pre-funded warrants referenced in Note 20 related to the equity line were exercised for a total of $200 in proceeds. Additionally, during the same period, the Company utilized the equity line to sell 3,072,054 shares for proceeds, net fees of $919,527.

 

During July 2025, the Company issued 6,000,000 shares of common stock to executives as part of compensation packages.

 

34

 

 

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 

 

Throughout this section, unless otherwise noted, “we,” “our,” “us,” “Cycurion” and the “Company” refer to Cycurion, Inc.

 

The following discussion is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with “Risk Factors,” “Special Note Regarding Forward-Looking Statements,” and our financial statements and related notes included in our Annual Report on Form 10-K for fiscal year 2024 filed with the SEC on April 17, 2025 (the “2024 Form 10-K”) and elsewhere in this Quarterly Report on Form 10-Q, as applicable.

 

Forward-Looking Statements

 

This quarterly report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. This includes, without limitation, statements regarding the financial position and the plans and objectives of management for our future operations. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this quarterly report on Form 10-Q, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strive,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.

 

These risks include the risks that are identified in the “Risk Factors” section of this quarterly report and of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and also include, among others, risks associated with the following:

 

the occurrence of any event, change or other circumstances, including the outcome of any legal proceedings that may be instituted against us;

 

the ability to maintain the listing of our securities on The Nasdaq Stock Market, and the potential liquidity and trading of our securities;

 

the risk of disruption to our current plans and operations;

 

the ability to recognize the anticipated benefits of our business and the recently closed de-SPAC transaction, which may be affected by, among other things, competition and the ability to grow, manage growth profitably, and retain key employees;

 

costs related to our business;

 

changes in applicable laws or regulations;

 

our ability to meet our future capital requirements to fund our operations, which may involve debt and/or equity financing, and to obtain such debt and/or equity financing on favorable terms, and our sources and uses of cash;

 

our ability to achieve and sustain profitability of our existing lines of business and through our wholly owned subsidiaries;

 

our ability to raise sufficient capital to continue to acquire cybersecurity companies;

 

our ability to attract and retain qualified cybersecurity talent;

 

our ability to successfully execute acquisitions, integrate the acquired businesses, and create synergies as a global cybersecurity consolidator;

 

our ability to efficiently acquire customers and maintain high client retention rates;

 

our ability to attract and retain qualified key technology or management personnel and to expand our management team;

 

our ability to stay in compliance with laws and regulations currently applicable to, or which may become applicable to our business both in the United States and internationally;

 

our ability to maintain existing license agreements;

 

our estimates regarding expenses, future revenue, capital requirements, and need for additional financing;

 

our ability to achieve and maintain profitability in the future;

 

our financial performance; and

 

other factors disclosed under the section entitled “Risk Factors” in this quarterly report on Form 10-Q.

 

These forward-looking statements are based on information available as of the date of this quarterly report on Form 10-Q and current expectations, forecasts, and assumptions, and involve a number of judgments, risks, and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.

 

35

 

 

General and Business Overview

 

We were originally incorporated as KAE Holdings, Inc., under the laws of the State of Delaware in 2017, with the purpose of acquiring and holding operating entities in the cybersecurity industry. On July 14, 2020, we changed our corporate name from KAE Holdings, Inc. to Cyber Secure Solutions, Inc., and, on February 24, 2021, to Cycurion, Inc.

 

We have one first-tier wholly-owned subsidiary, Cycurion Sub, Inc. (formerly Cycurion, Inc., until February 14, 2025), and three indirectly wholly-owned second-tier subsidiaries: (i) Axxum Technologies LLC (“Axxum”), a Virginia limited liability company formed in December 2006, (ii) Cloudburst Security LLC (“Cloudburst”), a Virginia limited liability company formed in January 2007, and (iii) Cycurion Innovation, Inc., a Delaware corporation formed in September 2021, in connection with our acquisition of assets from Sabres Security Ltd. (“Sabres”), a leading Israeli-based cyber security provider.

 

We deliver high-quality, cybersecurity solutions to federal government civilian, defense, and judiciary agencies in addition to commercial clients across a variety of industries. Through our operating subsidiaries and strategic partnerships, we have numerous prime and subcontracts with key government agencies. Our growth engine is driven by organic business solutions and strategic acquisitions of cyber/ infrastructure service providers.

 

Our Subsidiaries

 

Cycurion Sub, Inc.

 

We own our operating subsidiaries through Cycurion Sub., Inc., a Delaware corporation that, until the closing date of the de-SPAC, was known as “Cycurion, Inc.” We continue to conduct our business through the three below-described entities, which are now indirectly wholly-owned second-tier subsidiaries by virtue of the recent closing of the de-SPAC transaction.

 

Axxum Technologies LLC

 

Organized in the Commonwealth of Virginia on December 29, 2006, Axxum is a cybersecurity provider with successful assignments within the multiple sub-agencies of the Department of Homeland Security. We acquired Axxum in November 2017. Following the acquisition, we continued Axxum’s core operations of providing contractor services to its existing federal government customer base while leveraging our existing processes and tools to expand its commercial footprint.

 

Cloudburst Security LLC

 

Cloudburst is a cybersecurity provider with successful assignments within highly sensitive government agencies and other commercial organizations. We acquired Cloudburst in April 2019. Following the acquisition, we continued Cloudburst’s core operations of providing mission-critical and highly sensitive government agencies and other commercial organizations with high-quality, innovative cybersecurity services. Cloudburst focuses on providing tailored solutions that leverage the industry’s best minds and technologies to predict, protect, detect, respond, and sustain our clients from the latest evolving cyber threats.

 

Cycurion Innovation, Inc.

 

Cycurion Innovation, Inc. was formed in connection with our acquisition of assets from Sabres, a leading Israeli-based cyber security provider. It operates our Cycurion Security Platform’s line of products allows our customers to improve their cyber posture with its MDP SaaS platform. This platform efficiently bundles and easily implements the external protection of a Web Application Firewall (“WAF”) and the internal protection of Bot Mitigation. Bot Mitigation is the reduction of risk to applications, Application Program Interfaces (APIs), and backend services from malicious bot traffic that fuels common automated attacks, such as Distributed Denial of Service (“DDoS”) campaigns and vulnerability probing. The costs of single-layer security can be measured in terms of money, time, and risk, as well as the damage wrought by a data breach, which millions of businesses experience each year. Through this interaction of the WAF and Bot Mitigation, the MDP is able to reinforce these layers of security and generate new security layers in real time in response to emerging threats. This process is directed by our Cycurion Security Platform’s proprietary, cloud-based artificial intelligence (“AI”) algorithm. Crucially, the AI underpinning the MDP platform is constantly evolving to counter new threats. Through a crowdsourcing process, the cloud-based MDP learns from every threat to any protected application and uses that newly acquired knowledge to protect all MDP clients better.

 

SLG Innovation, Inc.

 

The SLG team has an average of over 25 years of experience in the development, planning, implementation, and management of information systems. SLG’s leadership team offers years of combined success in answering the needs of government agencies and healthcare organizations across the country.

 

36

 

 

The SLG team has worked nationally, as it has served over 25 Department of Health and Human Services agencies, all 50 state governments, and over 250 local governments. Since SLG’s inception, it has primarily focused on customers in the middle of the country. The team of professionals has successfully delivered Information Technology, Project Management, and Subject Matter Services to key health and human service projects, including, but not limited to, state Medicaid programs in Illinois, Indiana, Nebraska, and Tennessee, the Indiana Division of Aging, Illinois Early Intervention, the University of Illinois Division of Specialized Care for Children, the Multiple Myeloma Research Foundation, and many more.

 

We established a subcontractor — prime contractor relationship with SLG in the fall of 2019, where we serviced several government agencies and commercial customers, State of New Mexico, Cognizant, KPMG, and the University of Illinois in support of SLG. Axxum Technologies and SLG Innovation that relationship in 2020. A subcontractor offers its specialized services to a prime contractor. Unlike prime contractors, who focus on the managerial side of the government contract, subcontractors tend to dedicate their efforts to lending subject matter expertise and delivery of service to the project. Technically strong subcontractors, along with a strong subcontractor plan are essential to boost the success of a project.

 

As a result of the strong technical skills and experience of the cyber teams at Cycurion and its subsidiaries, SLG Innovation entered into a Master Services Agreement (MSA) with Axxum Technologies to provide services to SLG customers. The MSA is task order driven and the number of task orders is modified periodically depending on actual customer requirements for IT and Cybersecurity services. Over the last three years, Axxum Technologies has assisted SLG Innovation in growing its revenue and customer base. As a result, SLG Innovation now represents a majority of Cycurion revenues.

 

SLG Acquisition Agreement

 

Our revenues from SLG in our 2024 and 2023 fiscal years were $14,703,887 and $13,837,042, respectively. The types of agreements to which SLG is a party are discussed under the heading “Our Business — Key Clients and Historical Performance.” From our perspective, a major benefit to us of the potential transaction contemplated by the SLG Term Sheet, as described below, would be that we could “piggyback” on SLG’s historical relationships with the various contracting governmental agencies in our bidding on future potential agreements. It is axiomatic in the governmental contracting arena in which we are involved that past performance on customer assignments as the prime contractor is one of the more important qualifications in competing for new opportunities within the federal government. We believe that our acquisition of SLG, if that transaction is closed by us, would yield such “past performance” qualifications.

 

On April 25, 2023, Cycurion Sub executed a Term Sheet with SLG (the “SLG Term Sheet”), pursuant to which SLG agreed to be acquired by Cycurion Sub. The Term Sheet contained all of the material terms and conditions of two proposed interrelated transactions to be memorialized by the SLG Acquisition Agreement. To effectuate the two transactions contemplated by the SLG Term Sheet, Cycurion Sub will form two subsidiaries, which, upon formation, will initially be wholly owned by Cycurion Sub. If, when, and as the transactions contemplated by the SLG Term Sheet are consummated, SLG would merge with and into one of the subsidiaries and survive, thereby becoming a wholly-owned subsidiary of Cycurion Sub. Because certain of the agreements to which SLG is the prime contractor require that the majority owner of the prime contractor be a resident of the City of Chicago or of Cook County (depending on the contract), contemporaneously with the consummation of the first of the two transactions, (i) SLG will divest itself of those agreements with the residency requirements, (ii) the second newly formed subsidiary will assume those agreements, (iii) Mr. Ed Burns will become the owner of a 51% interest in that newly formed subsidiary, and (iv) we will enter into a Management Agreement with that subsidiary, the economic terms and management/ control terms of which are intended to be the equivalent of complete ownership of that the 49% owned subsidiary. Mr. Ed Burns is currently the 51% owner of SLG and a resident of the City of Chicago. The SLG Term Sheet provides that, if, when, and as the transactions contemplated thereby are consummated, the two current owners of SLG will be issued an aggregate of 996,355 shares of Cycurion common stock.

 

SLG is fully bound by the terms and provisions of the SLG Term Sheet and the related Management Agreement structure, although Cycurion Sub is permitted to terminate the SLG Term Sheet and to abandon the transactions contemplated thereby any time for any reason or for no reason prior to April 11, 2025, with no further obligations on Cycurion Sub’s part. As of the date of this quarterly report, although we reserve the right to modify the terms and provisions of the SLG Acquisition Agreement, we do not currently expect to terminate it and currently expect to close the transactions contemplated during our current fiscal quarter. Substantially all of the agreements to which SLG is a party have a provision that provides the counterparty to such agreement with a right to approve an assignment or change in control of SLG prior to its effectiveness. If an approval is not forthcoming, then the provisions of the SLG Acquisition Agreement permit us to excise that specific agreement. Upon such occurrence, we reserve that right to reduce the consideration that we would otherwise tender to the equity owners of SLG.

 

37

 

 

As amended by the parties, initially effective as of November 29, 2023 and subsequently effective as of April 29, 2024, August 16, 2024 and December 31, 2024, the SLG Term Sheet expires on the soonest of (i) closing of the transactions contemplated thereby, (ii) April 11, 2025, if the transactions contemplated thereby have not closed by then, (iii) Cycurion Sub’s termination thereof, and (iv) the mutual termination by all of the parties thereto. Notwithstanding anything to the contrary contained therein, Cycurion Sub may terminate its obligations under the SLG Term Sheet and the transactions contemplated hereby for any reason or for no reason without any further obligations and without any liability at any time through and including April 11, 2025. The SLG Term Sheet, as amended, consensually superseded, as noted therein, Cycurion Sub’s previous “unidirectional” agreements with SLG.

 

The foregoing brief summary description of certain terms and provisions of (i) the SLG Term Sheet does not purport to be complete and is qualified in its entirety by reference to the full text of the SLG Term Sheet, a copy of which is attached to this Annual Report as Exhibit 10.12, (ii) the SLG Term Sheet Amendments, a copy of each of which is attached to this Annual Report as Exhibit 10.12a, Exhibit 10.12b, Exhibit 10.12c, and Exhibit 10.12d, and (iii) the SLG Management Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the SLG Term Sheet, a copy of which is attached to the Annual Report on Form 10-K filed with the SEC on April 17, 2025 as Exhibit 10.12e. Readers are encouraged to read those Exhibits in full for a more comprehensive understanding of the transaction contemplated by the SLG Term Sheet.

 

RCR Acquisition Agreement

 

RCR Technology Corporation (“RCR”) performs certain services for SLG in its role as an SLG subcontractor and, in that context, became a creditor of SLG. In connection with the transactions contemplated by the SLG Term Sheet, on April 25, 2023, Cycurion and RCR also entered into a term sheet (the “RCR Term Sheet”) for a distinct, but related transaction. The RCR Term Sheet contemplates a transaction, pursuant to which RCR will sell to Cycurion all of the accounts receivable of SLG in favor of RCR (but for those accounts that are less than 90 days old as of the date of consummation of the contemplated transaction). The consummation of the transactions contemplated by the RCR Term Sheet is contingent upon the consummation of the transactions contemplated by the SLG Term Sheet. Nevertheless, as a result of our entry into the SLG Management Agreement with SLG, we still currently intend to consummate the transactions contemplated by the RCR Term Sheet in the second half of our current fiscal year. The RCR Term Sheet provides that, if, when, and as the transactions contemplated thereby are consummated, RCR will be issued shares of our common stock.

 

Further, as amended by the parties, initially effective as of November 29, 2023, and subsequently effective as of April 29, 2024, August 16, 2024 and December 31, 2024, the RCR Term Sheet expires on the soonest of (i) closing of the transactions contemplated thereby, (ii) April 11, 2025, if the transactions contemplated thereby have not closed by then, (iii) Cycurion’s termination thereof, and (iv) the mutual termination by all of the parties thereto. Notwithstanding anything to the contrary contained therein, Cycurion may terminate its obligations under the RCR Term Sheet and the transactions contemplated hereby for any reason or for no reason without any further obligations and without any liability at any time through and including April 11, 2025. As of the date of this quarterly report, we do not currently expect to terminate the transactions contemplated by the RCR Term Sheet, as amended, and currently expect to close the transactions in the second half of our current fiscal year.

 

The foregoing brief summary description of certain terms and provisions of the RCR Term Sheet does not purport to be complete and is qualified in its entirety by reference to the full text of the RCR Term Sheet, a copy of which is attached to the Annual Report on Form 10-K filed with the SEC on April 17, 2025 as Exhibit 10.13 and the full text of the RCR Term Sheet Amendments, a copy of each of which are attached to the Annual Report on Form 10-K filed with the SEC on April 17, 2025 as Exhibit 10.13a, 10.13b and 10.13c. Readers are encouraged to read those Exhibits in full for a more comprehensive understanding of the transaction contemplated by the RCR Term Sheet.

 

Acquisition of Technology

 

Sabres SaaS Asset Purchase

 

On August 17, 2021, we entered into an asset purchase agreement to acquire certain technology assets of Sabres, a leading Israeli-based cyber security provider. As part of the asset purchase agreement, we acquired Multi-Dimensional Protection, Web Application Firewall and Bot Mitigation SaaS platforms, and their associated intellectual property. The transaction closed on September 30, 2021, and we have integrated the SaaS platforms into our existing services offerings.

 

Our Cycurion Security Platform’s (formerly Sabres’) line of products allows our customers to improve their cyber posture with its MDP SaaS platform. This platform efficiently bundles and easily implements the external protection of a Web Application Firewall (WAF) and the internal protection of Bot Mitigation. Bot Mitigation is the reduction of risk to applications, Application Program Interfaces (APIs), and backend services from malicious bot traffic that fuels common automated attacks, such as DDoS campaigns and vulnerability probing. The costs of single-layer security can be measured in terms of money, time, and risk, as well as the damage wrought by a data breach, which millions of businesses experience each year. Through this interaction of the WAF and Bot Mitigation, the MDP is able to reinforce these layers of security and generate new security layers in real time in response to emerging threats. This process is directed by our Cycurion Security Platform’s proprietary, cloud-based AI algorithm. Crucially, the AI underpinning the MDP platform is constantly evolving to counter new threats. Through a crowdsourcing process, the cloud-based MDP learns from every threat to any protected application and uses that newly acquired knowledge to protect all MDP clients better.

 

38

 

 

Our Cycurion Security Platform’s (formerly Sabres’) line of products provides solutions for substantially all web application security needs. These products provide solutions, whether a client is in need of a web application firewall to comply with regulations and ensure it has a first line of defense against the hazards that the internet can present or is in need of enterprise-level products that empower Security Operations Center (SOC) teams and security management. Our Cycurion Security Platform’s constantly survey a client’s data to detect security issues in need of attention, send automatic updates, and provide the client with a complete database of rules and threats.

 

We have integrated the technology assets that we acquired from Sabres (which now constitutes our Cycurion Security Platform) into our Managed Security Services Practice. We believe that the platform will enhance our service offerings and assist with the expansion of our commercial business. The Sabres platform will be managed by our dedicated support team, and will provide real time reporting, response to security incidents, and will manage all data privacy needs from a single SIEM SaaS platform dashboard.

 

Financial Overview

 

A number of factors have contributed to our second quarter of fiscal year 2025 results of operations, the most significant of which are described below. More details on these changes are presented below within our “Results of Operations” section.

 

  The execution of the SLG Innovation Inc. acquisition.

 

  ●  The completion of the business combination with Western Acquisition Ventures Corp. 

 

Results of Operations

 

Table MD&A 1: Consolidated Results of Operations

 

 

   For the Three Months Ended   For the Six Months Ended 
   June 30, 2025   June 30, 2024   June 30, 2025   June 30, 2024 
Net revenues  $3,887,915   $5,001,312   $7,757,965   $9,244,167 
Cost of revenues   3,651,978    3,977,150    6,844,265    7,873,291 
Gross profit   235,937    1,024,162    913,700    1,370,876 
Gross profit percentage   6.1%   20.5%   11.8%   14.8%
Operating expenses:                    
Selling, general and administrative expenses   4,002,018    294,790    14,777,281    673,767 
Operating (loss)/income   (3,766,081)   729,372    (13,863,581)   697,109 
Interest income   -    20,211    -    20,211 
Interest expense   (615,392)   (482,355)   (794,283)   (713,830)
Loss on debt settlement, net   (907,983)   -    (766,330)   - 
Other (expense)/income   (962)   38,866    (114,706)   (9,871)
Other expense, net   (1,524,337)   (423,278)   (1,675,319)   (703,490)
(Loss)/income before income taxes   (5,290,418)   306,094    (15,538,900)   (6,381)
Provision for income tax   -    -    -    - 
Net (loss)/income  $(5,290,418)  $306,094   $(15,538,900)  $(6,381)
Less: Net loss attributable to non-controlling interest   (101,659)   -    (101,659)   - 
Net (loss)/income attributable to Cycurion  $(5,188,759)  $306,094   $(15,437,241)  $(6,381)

 

Revenue

 

Revenues for the three months ended June 30, 2025 decreased $1,113,397 or 22% compared to the three months ended June 30, 2024. For the six months ended June 30, 2025, revenues decreased by $1,486,202 or 16% compared to same period in 2024.

 

We attribute this decrease in the revenues in 2025 compared to 2024 to delayed start dates of new federal, state and local contracts and the company’s focus on more profitable business.

 

39

 

 

Cost of Revenue

 

The cost of revenue for the three and six months ended June 30, 2025, was approximately $3,651,978 and $6,844,265, respectively, compared to $3,977,150 and $7,873,291 for the same periods in 2024, respectively. The cost of revenue is driven by the costs incurred while delivering services to our customers.

 

Selling, general and administrative (“SG&A”) expenses

 

Our selling, general and administrative (“SG&A”) expenses increased in 2025 compared to 2024 due to additional expenses being recognized in 2025 related to merger and acquisition efforts in the legal, administrative, and consulting operations. While costs associated with the Western merger are considered one-time costs, there will be continued SG&A costs greater than the 2024 amounts as the company expands.

 

Interest expense

 

Interest expense for the three and six months ended June 30, 2025 was $615,392 and $794,283, respectively, compared to $482,355 and $713,830 for the three and six months ended June 30, 2024. The change in interest expense is a result of a the underlying debt instruments. For further information refer to debt footnotes.

 

Liquidity and Capital Resources

 

Our primary sources of liquidity are cash on hand, cash from operations, borrowings under our debt financing arrangements and equity raises through our equity line. As of June 30, 2025, we had $1,013,836 in cash and cash equivalents. We believe that our current cash position, access to the capital markets and cash flow generated from operations should be sufficient for our operating requirements through the next several fiscal years.

 

Cash Flow

 

Table MD&A 2: Net Changes in Cash and Cash Equivalents

 

   For the Six Months Ended 
   June 30, 2025   June 30, 2024 
Net cash used in operating activities  $(6,303,122)  $(850,413)
Net cash provided by/(used in) investing activities   1,695,523    (592,000)
Net cash provided by financing activities   5,580,645    1,032,678 
Net increase/(decrease) in cash and cash equivalents  $973,046   $(409,735)

 

Net Cash Used In Operating Activities

 

For the six months ended June 30, 2025, net cash used by operating activities was $6,303,122, compared to $850,413 for the six months ended June 30, 2024. The main driver of this increase is the additional merger expenses incurred in 2025.

 

Net Cash Provided By/(Used In) Investing Activities

 

For the six months ended June 30, 2025, net cash provided in investing activities was approximately $1,695,523, compared to a $592,000 use of cash for the six months ended June 30, 2024. The cash inflow in 2025 was a result of the Trust Account for redemption and cash released from the Trust Account to the Company.

 

Net Cash Provided by Financing Activities

 

For the six months ended June 30, 2025, net cash provided by financing activities was $5,580,645. The net cash provided includes $3,664,671 proceeds provided from the exercise of warrants, $2,376,500 in proceeds from convertible notes payable, $1,001,216 cash used in redemption of common stock for redemption, $513,200 in proceeds provided from notes payable, $265,504 in proceeds from the equity line of credit and $20,000 used in the repayment of other notes payable.

 

For the six months ended June 30, 2024, net cash provided by financing activities was $1,032,678. The company received $1,000,000 from a private placement.

 

40

 

 

Going Concern

 

We have incurred operating losses since inception through the period ended June 30, 2025, having had negative cash flow from operations. As of June 30, 2025, we had an accumulated deficit of approximately $18,853,937, as compared to our accumulated deficit of approximately $3,203,361 as of December 31, 2024. The increase of our accumulated deficit was a result of our net losses for the six months ended June 30, 2025.

 

Furthermore, we expect continued, significant operating losses for the next few years. We also utilized cash in operations of approximately $6,303,122 in the six months ended June 30, 2025. As of June 30, 2025, we had unrestricted cash of approximately $1.0 million, an increase of $1.0 million from approximately $38,000 at December 31, 2024. As of June 30, 2025, our total assets increased to approximately $30.7 million from approximately $25.6 million at December 31, 2024, primarily due to increases in goodwill. Based on our current capital resources as of June 30, 2025, including our unrestricted cash and accounts receivable, net of $4.1 million, we expect to be able to continue our operations for a minimum of 12 months as of the date of this quarterly report. Nevertheless, our continuation as a going concern is dependent on our ability to obtain additional financing until we can generate sufficient, consistent cash flow from operations to meet the expected growth in our obligations. We intend to continue to seek additional debt or equity financing to continue our operations.

 

Our consolidated financial statements have been prepared on a going concern basis, which implies we may not continue to meet our obligations and continue our operations for the next fiscal year. The continuation of our Company as a going concern is dependent upon our ability to obtain necessary debt or equity financing to continue operations until we begin generating positive cash flow.

 

There is no assurance that we will ever be consistently profitable or, notwithstanding our recent financing activities, that debt or equity financing will be available to us in the amounts, on terms, and at times deemed acceptable to us, if at all. The issuance of additional equity securities by us would result in a significant dilution in the equity interests of our current stockholders. Obtaining commercial loans, assuming those loans would be available, would increase our liabilities and future cash commitments. If we are unable to obtain financing in the amounts and on terms deemed acceptable to us, we may be unable to continue our business, as planned, and as a result may be required to scale back or cease operations for our business, the result of which would be that our stockholders would lose some or all of their investment. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should we be unable to continue as a going concern.

 

Off-balance sheet arrangements

 

We did not have any off-balance sheet arrangements during the periods presented, and we do not currently have any off-balance sheet arrangements, as defined in the SEC rules and regulations.

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates, judgments, and assumptions that affect the amounts reported. Actual results could differ from those estimates. The 2024 Form 10-K, as filed with the SEC on April 17, 2025, includes a summary of critical accounting policies we believe are the most important to aid in understanding our financial results. There have been no changes to those critical accounting policies that have had a material impact on our reported amounts of assets, liabilities, revenues, or expenses during the six months ended June 30, 2025.

 

41

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

As a “smaller reporting company,” as that term is defined in Rule 229.10(f)(1), we are not required to provide the information required by this Item.

 

Item 4. Controls and Procedures

 

Management’s Evaluation of Disclosure Controls and Procedures.

 

Cycurion maintains disclosure controls and procedures designed to ensure that information required to be disclosed in its periodic filings under the Securities Exchange Act of 1934 (“Exchange Act”), including this Quarterly Report on Form 10-Q, is recorded, processed, summarized, and reported on a timely basis. These disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed under the Exchange Act is accumulated and communicated to Cycurion’s management on a timely basis to allow decisions about required disclosure. Management, including Cycurion’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of Cycurion’s disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of June 30, 2025.

 

Cycurion carried out the evaluation of the effectiveness of its disclosure controls and procedures, required by paragraph (b) of Exchange Act Rules 13a-15 and 15d-15, under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer. Based upon this evaluation, the Chief Executive Officer and Chief Financial Officer concluded that Cycurion’s disclosure controls and procedures were effective as of June 30, 2025.

 

Changes in Internal Control Over Financial Reporting.

 

There were no changes in Cycurion’s internal control over financial reporting during the quarter ended June 30, 2025 that have materially affected, or are reasonably likely to materially affect, Cycurion’s internal control over financial reporting.

 

42

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

On July 29, 2024, Object3, LLC initiated an arbitration proceeding with the American Arbitration Association, styled Object3, LLC, Claimant, v. Cloudburst Security, LLC, Respondent, Case No. 01-24-0006-9906. The claimant made claims against Cloudburst for unpaid consulting services and associated costs, fees, and interest for the prior 12-month period in the aggregate amount of approximately $228,000. Defendant Cloudburst (a wholly-owned subsidiary) denies that it owes such amount to Claimant. As of the date of this Quarterly Report on Form 10-Q, the arbitration proceeding has been settled. 

 

We know of no other material pending legal proceedings to which we or any of our subsidiaries are a party or to which any of our assets or properties, or the assets or properties of any of our subsidiaries, are subject and, to the best of our knowledge, no adverse legal activity is anticipated or threatened. In addition, we do not know of any such proceedings contemplated by any governmental authorities.

 

We know of no material proceedings in which any of our directors, officers, or affiliates, or any registered or beneficial stockholder is a party adverse to us or any of our subsidiaries or has a material interest adverse to us or any of our subsidiaries.

 

Item 1A. Risk Factors

 

In connection with information set forth in this Form 10-Q, the factors discussed below and under “Risk Factors” in our Form 10-K for fiscal year ended December 31, 2024, should be considered. The risks included below and in the Form 10-K could materially and adversely affect our business, financial condition and results of operations.

 

Other than as set forth below, there have been no material changes to the factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the Securities and Exchange Commission on April 17, 2025.

 

Our business could be adversely affected by legislative or government budgetary and spending changes.

 

The market for our services depends largely on domestic and international legislative programs and the budgetary capability to support programs, including the continuance of existing programs. Many of our contracts are not fully funded at inception and rely upon future appropriations of funds. Accordingly, a failure to receive additional anticipated funding may result in early termination of a contract. In addition, many of our contracts include clauses that allow clients to unilaterally modify or terminate contracts with little or no recompense. Decreases in funding for, or delays in contract awards and in government spending on the types of programs that we support, and terminations or price reductions on government contracts on which we are currently performing could adversely affect our future revenues and profitability.

 

Changes in state or federal government initiatives or in the level of government spending due to budgetary or deficit considerations may have a significant impact on our future financial performance. In recent quarters, the U.S. Federal Government has placed a significant focus on efficiency, including with respect to contracting with private companies. These efforts have and may continue to have effects on our business, including, but not limited to:

 

  Changes in priorities may result in procurement changes, delays or cancellations, as well as changes in scope, pricing, or outright cancellations of existing contracts.
     
  Changes in priorities may also affect the level of demand or funding for our state programs in the United States, which are typically mandated and fully or partially funded from the U.S. Federal Government.
     
  Changes to procurement rules may result in additional competition, scrutiny and costs of compliance.
     
  Changes in federal regulations, such as those related to the elimination of diversity, equity and inclusion initiatives, or return to office mandates may require us to change our existing business practices, may be disruptive to our business, may create a level of uncertainty within our workforce and may conflict with local laws and regulations.
     
  The U.S. Government may seek to lower barriers to entry to allow greater involvement by the private sector. While this may provide additional opportunities for us, it may also expose us to greater levels of competition. 

 

43

 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

(a)There were no unregistered sales of equity securities for the six months ended June 30, 2025.

 

a.On April 7, 2025, we entered into a pre-funded warrant (“Pre-Funded Warrant”) with Yield Point NY LLC (the “Investor”) for up to 4,500,000 shares of Common Stock issuable to the Investor upon exercise of the Pre-Funded Warrant. We chose to issue the Pre-Funded Warrant in consideration for the Investor’s execution and delivery of the Equity Purchase Agreement, dated April 7, 2025, between us and the Investor in lieu of paying the Investor $1,800,000 in cash.

 

(b)None.

 

(c)None.

 

Item 3. Defaults Upon Senior Securities

 

(a)None.

 

(b)None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

(a)None.

 

(b)None.

 

(c)During the three months ended June 30, 2025, no director or officer of the Company adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

Item 6. Exhibits

 

Exhibit No.   Description of Exhibit
31.1 Certification of Chief Executive Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002
     
31.2 Certification of Chief Financial Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002
     
32.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002
     
101.INS Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
     
101.SCH Inline XBRL Taxonomy Extension Schema
     
101.CAL Inline XBRL Taxonomy Extension Calculation
     
101.DEF Inline XBRL Taxonomy Extension Definition
   
101.LAB Inline XBRL Taxonomy Extension Label
     
101.PRE Inline XBRL Taxonomy Extension Presentation
   
104 Cover Page Inline Interactive Data File - the cover page interactive data files does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document included as Exhibit 101
     
  Filed herewith.
  Furnished herewith.

 

44

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Cycurion Inc.

   
       
By: /s/ L. Kevin Kelly   August 13, 2025

L. Kevin Kelly

   
  Chief Executive Officer    
  (Principal Executive Officer)    
       
  /s/ Alvin McCoy III   August 13, 2025
By: Alvin McCoy III    
  Chief Financial Officer    
  (Principal Financial Officer and Principal Accounting Officer)    

 

45